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 The	  blood-­‐retinal	  barrier	   (BRB),	   located	   in	   the	  posterior	  part	  of	   the	  eye,	  has	  
the	   role	   to	   regulate	   the	   microenvironment	   of	   retinal	   visual	   cells.	   However,	   due	   to	  
some	  alterations	  concerning,	  for	  instance,	  the	  unbalance	  between	  the	  production	  and	  
degradation	  of	  reactive	  oxygen	  species	  (ROS)	  in	  the	  retina,	  the	  barrier	  function	  can	  be	  
compromised.	  As	   a	   consequence,	   some	  pathological	   conditions	   can	   emerge,	   like	   the	  
age-­‐related	  macular	  degeneration	  (AMD),	  a	  chronic	  disease	  responsible	  for	  the	  loss	  of	  
central	  vision	  due	  to	  the	  gradual	  deterioration	  of	  the	  macula.	  Currently	  there	  is	  no	  way	  
of	  preventing	  or	  curing	  this	  form	  of	  degeneration.	  	  
	   The	   BIOAMD	   -­‐	   Biomaterials	   for	  modulation	   of	   inflammation	   in	   Age	   Related	  
Macular	  Degeneration	  project	  proposes	  a	  new	   therapeutic	   strategy	   to	   treat	  AMD	  by	  
modulating	   the	  ROS	  unbalance	  by	  means	  of	   the	  design	  of	  an	   implantable	   composite	  
material	  made	  from	  poly(methyl	  methacrylate)	  (PMMA)	  and	  titanium	  dioxide	  (TiO2).	  As	  
part	   of	   this	   project,	   the	   aim	   of	   this	   thesis	   was	   to	   chemically	   and,	   subsequently,	  
biologically	   (using	   a	   barrier	   system	   with	   macrophages)	   analyze	   the	   ROS	   scavenging	  
capacity	  of	  different	  TiO2	  powders.	  These	  included,	  TiO2	  powders	  calcined	  at	  different	  
temperatures	  –	  200°C,	  600°C	  and	  700°C	  –	  as	  well	  as	  mixtures	  of	  the	  powders	  calcined	  
at	   200°C	   and	   700°C.	   The	   goal	   was	   to	   assess	   the	   impact	   of	   the	   different	   physico-­‐
chemical	  properties	  of	  the	  TiO2	  powders	  –	  crystalline	  network	  arrangement	  and	  grain	  
size	  –	  on	   the	  ROS	  scavenging	  capacity.	  This	  was	   firstly	   tested	  under	   static	  conditions	  
and	  then	  transposes	  to	  a	  dynamic	  environment,	  essential	   to	  better	  mimic	  the	   in	  vivo	  
conditions,	  by	  using	  a	  bioreactor	  system.	  	  
	   Using	   two	  distinctive	   chemical	   assays	  based	  on	  2,2-­‐diphenyl-­‐1-­‐picrylhydrazyl	  
(DPPH)	  or	  3-­‐morpholinosyndnomine	  (SIN-­‐1)	   it	  was	  determined	  that	  the	  200°C	  (100	  %	  
of	   anatase	   phase	   and	   with	   a	   grain	   size	   of	   2-­‐30	   µm)	   and	   600°C	   (77	   %	   and	   23	   %	   of	  
anatase	  and	  rutile	  phase	  and	  with	  a	  grain	  size	  of	  0,5-­‐50	  µm)	  calcined	  powders,	  showed	  
the	  highest	  percentage	  of	  ROS	  scavenging,	  which	  varies	  from	  50%	  to	  70%.	  	  	  
	   Subsequently	  the	  scavenging	  capacity	  of	  the	  powders	  of	  biologically	  produced	  
ROS	   was	   assessed	   using	   macrophage	   cultures.	   Non-­‐activated	   or	   activated	  
macrophages	  were	  cultured	  on	  transwell	  membranes.	  On	  the	  bottom	  of	  the	  well	  plate	  
the	   TiO2	   powders	   (200°C	   or	   600°C	   calcined	   powders	   and	   a	   commercial	   powder	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containing	  6	  %	  and	  94	  %	  of	  anatase	  and	  rutile	  phase	  and	  a	  grain	  size	  of	  0,5-­‐1µm)	  were	  
added	   at	   two	   concentrations	   -­‐	   1	   mg/ml	   and	   5	   mg/ml.	   The	   macrophages	   metabolic	  
activity	   after	   24	   hrs	   and	   48	   hrs,	   in	   all	   cases,	   has	   been	   kept	   around	   100%.	   The	   extra	  
(bottom	  compartment)	  and	   intracellular	  ROS	  analysed	  after	  48	  hrs	  were	   significantly	  
reduced	   when	   the	   macrophages	   were	   cultured	   in	   the	   presence	   of	   the	   powders.	  
Noteworthy,	  no	  significant	  differences	  were	  verified	  either	  between	  TiO2	  powders	  or	  
concentrations.	  	  	  
	  	   Lastly,	   the	   dynamic	   environment	   was	   assessed	   in	   a	   bioreactor	   system.	   In	   a	  
first	  place	  was	  tested	  its	  permeability	  using	  DPPH	  and	  SIN-­‐1	  under	  static,	  as	  a	  control,	  
and	  dynamic	  conditions	  –	  150	  or	  200	  µl/min	  for	  the	  bottom	  chamber	  and	  300	  or	  400	  
µl/min	   for	   the	   upper	   chamber.	   The	   results	   revealed	   ROS	   diffusion	   through	   the	  
polycarbonate	   membrane.	   Nevertheless,	   it	   was	   also	   possible	   to	   observe	   some	  
interactions	   between	   the	   membrane	   and	   the	   analysed	   compounds.	   Afterwards,	  
macrophages	  were	   seeded	   on	   the	   top	   of	   the	  membrane	   and	   the	   experiments	  were	  
performed	  in	  static	  and	  dynamic	  conditions	  –	  150	  µl/min	  for	  the	  bottom	  chamber	  and	  
300	  µl/min	  for	  the	  upper	  chamber.	  The	  results	  revealed	  that	  the	  presence	  of	  flow	  upon	  
48	   hrs	   reduces	   the	   cell	   viability.	   The	   ROS	   levels	  were	   similar	   in	   both	   chambers.	   The	  
presence	   of	   flow,	   however,	   led	   to	   an	   increase	   in	   ROS	   levels	   in	   non-­‐activated	  
macrophages	  indicating	  a	  possible	  activation.	  	  
	   Overall,	  this	  work	  demonstrated	  that	  TiO2	  powders,	  mainly	  the	  ones	  calcined	  
at	   200°C	   and	   600°C	   are	   good	   scavengers	   at	   both	   chemical	   and	   cellular	   levels.	  
Furthermore	   the	   bioreactor	   system	   represents	   a	   valuable	   input	   for	   further	   simulate	  








A	  barreira	  hemato-­‐retiniana	   (BHR),	   localizada	  na	  parte	  posterior	  do	  olho,	   tem	  
como	  função	  regular	  o	  microambiente	  das	  células	  visuais	  da	  retina.	  No	  entanto,	  devido	  
a	  algumas	  alterações	  como	  o	  desequilíbrio	  entre	  a	  produção	  e	  degradação	  de	  espécies	  
reactivas	   de	   oxigénio	   (ERO)	   na	   retina,	   as	   funções	   da	   barreira	   podem	   ficar	  
comprometidas.	  Como	  consequência,	  podem	  surgir	  condições	  patológicas	  tais	  como	  a	  
degeneração	  macular,	   relacionada	   com	   a	   idade,	   (DMRI).	   Esta	   é	   uma	   doença	   crónica	  
responsável	   pela	   perda	   de	   visão	   central	   devido	   à	   gradual	   deterioração	   da	   macula.	  
Actualmente	  não	  existe	  forma	  de	  prevenção	  ou	  cura	  para	  esta	  degeneração.	  	  
O	   projecto	   BIOAMD	   –	   biomateriais	   para	   a	   modelação	   da	   inflamação	   na	  
degeneração	   macular,	   relacionada	   com	   a	   idade	   propõe	   uma	   nova	   estratégia	  
terapêutica	  para	  o	  tratamento	  da	  DMRI	  através	  da	  modelação	  do	  desequilíbrio	  de	  ERO	  
usando	  um	  material	  compósito	  constituído	  por	  Poli(metacrilato	  de	  metilo)	  (PMMA)	  e	  
dióxido	  de	  titânio	  (TiO2).	  O	  objectivo	  desta	  tese,	  como	  parte	  integrante	  do	  projecto,	  foi	  
analisar	  quimicamente	  e,	  consequentemente,	  biologicamente	  (usando	  um	  sistema	  de	  
barreira	   constituído	   por	   macrófagos)	   a	   capacidade	   de	   eliminação	   de	   ERO	   por	  
diferentes	   tipos	  de	  pós	  de	  TiO2	   calcinados	  a	  diversas	   temperaturas	  –	  200°C,	   600°C	  e	  
700°C	  –	  e	  também	  misturas	  de	  pós	  calcinados	  a	  200°C	  e	  700°C.	  O	  objectivo	  foi	  avaliar	  o	  
impacto	   das	   diferentes	   propriedades	   físico-­‐químicas	   dos	   pós	   de	   TiO2	   -­‐	   arranjo	   rede	  
cristalina	  e	  o	  tamanho	  dos	  grãos	  -­‐	  na	  capacidade	  de	  eliminação	  de	  ERO.	  	  Em	  primeiro	  
lugar,	   isto	   foi	   testado	   em	   condições	   estáticas	   e,	   em	   seguida,	   transposto	   para	   um	  
ambiente	   dinâmico,	   essencial	   melhor	   mimetizar	   as	   condições	   in	   vivo,	   utilizando	   um	  
sistema	  de	  bioreactor.	  
Usando	  dois	  ensaios	  químicos	  distintos	  com	  base	  em	  2,2-­‐difenil-­‐1-­‐picrilhidrazilo	  
(DPPH)	  ou	  3-­‐morpholinosyndnomine	  (SIN-­‐1),	  concluiu-­‐se	  que	  os	  pós	  calcinados	  a	  200°C	  
(100%	  de	  fase	  de	  anatase	  e	  com	  um	  tamanho	  de	  grão	  de	  2-­‐30	  µm)	  e	  600°C	  (77%	  e	  23%	  
de	   fase	   de	   anatase	   e	   rutilo	   e	   com	   um	   tamanho	   de	   grão	   de	   0,5-­‐50	   µm)	   	  mostram	   a	  
maior	  percentagem	  de	  eliminação	  de	  ROS,	  que	  varia	  entre	  50%	  a	  70%.	  
Subsequentemente,	   a	   capacidade	   de	   eliminação	   de	   ERO	   producidos	  
biologicamente	  pelos	  pós	   foi	  avaliada	  utilizando	  culturas	  de	  macrófagos.	  Macrófagos	  
não	   ativados	   ou	   ativados	   foram	   cultivadas	   em	  membranas	   transwell.	   No	   fundo	   dos	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poços	   foram	   colocados	   os	   pós	   de	   TiO2	   (200°C	   ou	   600°C	   e	   pós	   calcinados	   um	   pó	  
comercial	  contendo	  6%	  e	  94%	  de	  anatase	  e	  rutilo	  de	   fase	  e	  um	  tamanho	  de	  grão	  de	  
0,5-­‐1μm)	  foram	  adicionados	  a	  dois	  -­‐	  concentrações	  de	  1	  mg/ml	  e	  5	  mg/ml.	  Em	  todos	  
os	  casos,	  a	  actividade	  metabólica	  dos	  macrófagos	  após	  24	  horas	  e	  48	  horas	  foi	  mantida	  
a	   cerca	   de	   100%.	   Os	   ERO	   extracelulares	   (compartimento	   inferior)	   e	   intracelulares,	  
analisadas	   após	  48	  horas,	   foram	   significativamente	   reduzidos	  quando	  os	  macrófagos	  
foram	  cultivados	  na	  presença	  dos	  pós.	  Não	  foram	  verificadas	  diferenças	  significativas,	  
quer	  entre	  os	  pós	  de	  TiO2	  ou	  concentrações.	  
Por	  fim,	  as	  condições	  dinâmico	  foram	  avaliadas	  num	  sistema	  de	  bioreactor.	  Em	  
primeiro	  lugar	  foi	  testado	  usando	  a	  sua	  permeabilidade,	  usando	  de	  DPPH	  e	  SIN-­‐1,	  em	  
condições	  estáticas,	  como	  um	  controlo,	  e	  as	  condições	  dinâmicas	  -­‐	  150	  ou	  200	  µl/min	  
para	   a	   câmara	   inferior	   e	   300	   ou	   400	   µl/min	   para	   a	   câmara	   superior.	   Os	   resultados	  
revelaram	   um	   perfil	   de	   difusão	   ROS	   através	   da	   membrana	   de	   policarbonato.	   No	  
entanto,	   foi	   também	  possível	   observar	   algumas	   interacções	   entre	   a	  membrana	   e	   os	  
compostos	   analisados.	   Em	   seguida,	   os	   macrófagos	   foram	   semeados	   no	   topo	   da	  
membrana	   e	   as	   experiências	   foram	   realizadas	   em	   condições	   estáticas	   e	   dinâmicas	   -­‐	  
150	  µl/min	  para	  a	  câmara	  inferior	  e	  300	  µl/min	  para	  a	  câmara	  superior.	  Os	  resultados	  
revelaram	  que	  a	  presença	  de	   fluxo	  após	  48	  horas	   reduz	  a	  viabilidade	  das	  células.	  Os	  
níveis	  de	  ERO	   foram	  semelhantes	  em	  ambas	  as	   câmaras.	  No	  entanto,	  a	  presença	  de	  
fluxo	  levou	  a	  um	  aumento	  nos	  níveis	  de	  ERO	  nos	  macrófagos	  não	  activados	  indicando	  
uma	  possível	  activação.	  	  
Em	   geral,	   este	   trabalho	   demonstrou	   que	   os	   pós	   de	   TiO2,	   principalmente	   os	  
calcinados	   a	   200°C	   e	   600°C,	   são	   bons	   eliminadores	   de	   ERO	   (ERO	   artificial	   ou	   ERO	  
produzidos	   biologicamente).	   Além	   disso,	   o	   sistema	   de	   bioreactor	   representa	   um	  
valioso	  contributo	  para	  simular	  a	  BHR	  e	  mais	  tarde	  estudar	  os	  biomateriais	  à	  base	  de	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Figure	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1.1 Blood-ocular barriers  
The	   inner	  part	  of	   the	  eye	   is	  composed	  by	  the	  aqueous,	   lens	  and	  vitreous	  and	  
must	  be	  protected	  from	  direct	  contact	  with	  blood	  vessels	  in	  order	  to	  maintain	  normal	  
visual	   function.	  The	  blood-­‐ocular	  barriers	  make	  this	  separation	  possible	   (1,2).	   In	   fact,	  
these	   barriers	   are	   responsible	   for	   the	   protection	   of	   the	   internal	   ocular	   tissues	   from	  
variations	   that	   occur	   in	   the	   circulation	   and	   are	   important	   for	   the	   regulation	   of	   the	  
inner	   fluid.	   Furthermore,	   these	   barriers	   assure	   the	   maintenance	   of	   the	   eye	   highly	  
regulated	   and	   chemically	   defined	   environment	   as	   well	   as	   a	   route	   to	   eliminate	   the	  
waste	  substances	  from	  metabolic	  activity	  (2).	  	  
The	   blood-­‐aqueous	   barrier	   (BAB)	   and	   blood-­‐retinal	   barrier	   (BRB)	   are	   the	   two	  
main	  barriers	  systems.	  The	  BAB	  is	  located	  in	  the	  anterior	  part	  of	  the	  eye	  and	  is	  formed	  
by	   endothelial	   cells	   of	   the	   iris	   blood	   vessels	   and	   a	   non-­‐pigmented	   cell	   layer	   of	   the	  
ciliary	  epithelium.	  This	  barrier	  is	  responsible	  for	  the	  equilibrium	  of	  inflow	  and	  outflow	  
of	  aqueous	  humor	  and	  consequently	  controls	   the	   intraocular	  pressure.	  The	  presence	  
of	  tight	  junctions	  is	  essential	  for	  the	  prevention	  of	  non-­‐specific	  traverse	  of	  solutes	  into	  
the	  internal	  ocular	  milieu	  (1).	  	  
The	  BRB	  is	  located	  in	  the	  posterior	  part	  of	  the	  eye	  and	  can	  be	  subdivided	  into	  
two	   structures:	   the	   inner	   part	   (iBRB)	   mainly	   composed	   by	   tight	   junctions	   between	  
endothelial	  cells	  of	  the	  retinal	  vessels	  and	  the	  outer	  part	  (oBRB)	  mainly	  composed	  for	  
analogous	   tight	   junctions	   in	   the	   retinal	   pigment	   epithelium	   (3).	   Together,	   the	   BRB	  
affects	  the	  outward	  movement	  of	  metabolic	  products	  from	  the	  retina	  into	  the	  blood,	  
thereby	  regulating	  the	  microenvironment	  of	  retinal	  visual	  cells	  (2).	  The	  loss	  of	  natural	  
configuration	  of	  BRB	  and,	  consequently,	  its	  normal	  functions,	  leds	  to	  the	  emergence	  of	  
pathologies	   such	  as	  age-­‐related	  macular	  degeneration	   (AMD)	  or	  diabetic	   retinopathy	  
(DR).	  Therefore,	  it	  is	  becoming	  more	  and	  more	  important	  to	  have	  a	  better	  knowledge	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1.2 Blood-retinal barrier 
The	   localization	   and	   the	   main	   components	   of	   the	   BRB	   are	   schematically	  
represented	  in	  Figure	  1.1.	  	  	  
	  
Figure	  1.1	  –	  Diagram	  of	  an	  eye	  cross	  section	  and	  the	  major	  cell	  layers	  of	  the	  retina,	  emphasizing	  the	  inner	  and	  outer	  
constitution	  of	  the	  BRB	  (4).	  	  
	  
1.2.1 Inner blood-retinal barrier  
Capillary	  endothelial	  cells,	  glial	  cells	  (Muller	  cells	  and	  astrocytes)	  and	  pericytes	  
constitute	  the	  inner	  blood-­‐retinal	  barrier	  (iBRB).	  	  
	  
Capillary endothelial cells  
	   Capillary	   endothelial	   cells	   form	   an	   endothelium	   responsible	   for	   the	  
establishment	  of	  a	  barrier	  between	  the	  blood	  and	  retinal	  tissue	  (2).	  These	  cells	  are	  not	  
fenestrated	  and	  have	  a	  scarcity	  of	  vesicles,	  responsible	  for	  endocytosis	  or	  transcytosis	  
(4).	   Additionally,	   the	  narrow	   intracellular	   tight	   junctions	   of	   capillary	   endothelial	   cells	  
form	  a	  network	  that	  is	  only	  present	  in	  vessels	  from	  the	  brain	  and	  the	  retina,	  although	  
in	  the	  retina	  these	  tight	  junctions	  are	  slightly	  more	  permeable	  (2).	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Glial cells    
Muller	  cells	  and	  astrocytes	  represent	  the	  major	  macroglial	  cells	  present	  in	  the	  
iBRB	   (5).	   These	   cells,	   along	   with	   pericytes,	   are	   associated	   with	   the	   regulation	   and	  
maintenance	   of	   the	   iBRB.	   The	   glial	   cells	   are	   responsible	   for	   the	   uptake	   of	  
neurotransmitters	   from	   nerve	   terminals	   but	   also	   secrete	   neuroactive	   agents	   like	  
neurotransmitters	  or	  neuropeptides	  and	  growth	  factors	  including	  vascular	  endothelial	  
growth	  factor	  (VEGF).	  	  
Muller	   cells	   play	   an	   essential	   role	   in	   the	   regulation	  of	   the	   extracellular	   space	  
volume,	   ion	   and	  water	   homeostasis,	   regulation	   of	   the	   retinal	   blood	   flow	   and	   in	   the	  
maintenance	   of	   the	   BRB.	   Moreover,	   these	   cells	   interact	   with	   neurons	   by	   providing	  
them	   throphic	   substances,	   removing	   metabolic	   waste	   and	   supports	   the	   synaptic	  
activity	  by	  neurotransmitter	  recycling	  which	  involves	  the	  supply	  of	  its	  precursors	  to	  the	  
neurons	  (6).	  	  
The	  role	  of	  astrocytes	   in	  retinal	  function	  is	   less	  understood.	  They	  do	  not	  have	  
processes	   that	   project	   to	   the	   synaptic	   layers	   of	   the	   retina	   and	   consequently	   cannot	  
regulate	  neuronal	  function	  similar	  to	  the	  Müller	  cells	  (7).	  Nonetheless,	  these	  cells	  are	  
known	   to	   modulate	   the	   normal	   development	   of	   retinal	   vascularization	   (8).	   Indeed,	  
astrocytes	  express	  VEGF	  during	  development	  (9),	  which	   is	  essential	   in	  the	  angiogenic	  
growth	  .	  Therefore,	  the	  growth	  of	  the	  inner	  retinal	  vasculature	  is	  intricately	  linked	  with	  
the	  function	  of	  astrocytes.	  	  
	  	  	  
Pericytes 	  
Pericytes	   are	   contractile	   cells	   that	   help	   to	   regulate	   regional	   blood	   flow	   (10).	  
Moreover,	   pericytes	   are	   responsible	   for	   the	   maintenance	   of	   capillary	   structure,	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1.2.2 Outer blood-retinal barrier 
The	  outer	  blood-­‐retinal	   barrier	   (oBRB)	   is	   formed	  by	   the	  photoreceptors	   (rods	  
and	  cones),	  the	  retinal	  pigment	  epithelium	  (RPE)	  and	  the	  Bruch’s	  membrane.	  	  	  
	  
Retinal pigment epithelium 
The	  RPE,	   located	   between	   the	   photoreceptors	   and	   the	  Bruch’s	  membrane,	   is	  
formed	  by	  a	  continuous	  monolayer	  of	  cuboidal	  post-­‐mitotic	  epithelial	  cells.	  The	  RPE	  is	  
responsible	   for	   the	   transport	   of	   ions,	   fluid	   and	   metabolites	   via	   lateral	   plasma	  
membrane	   barrier	   junctions.	   The	   transport	   of	   ions	   is	   crucial	   for	   the	  
polarisation/hyperpolarisation	  of	   the	  cell	  membranes.	  Moreover,	  a	  number	  of	  amino	  
acids	   like	   taurine,	   alanine,	   glutamine	   and	   leucine	   are	   absorbed	   across	   the	   RPE	   (12).	  
Additionally,	   the	   RPE	   cells	   are	   important	   in	   the	   transport	   and	   storage	   of	   retinoids,	  
which	  are	  fundamental	  of	  the	  visual	  cycle.	  The	  RPE	  has	  a	  phagocytic	  activity	  assuring	  
the	  phagocytosis	  of	  the	  photoreceptors	  outer	  segments.	  	  
Due	   to	   the	   exposure	   to	   visible	   light	   and	   high	   local	   oxygen	   tensions,	   the	   RPE	  
emerge	   as	   a	   favourable	   environment	   for	   the	   production	   of	   reactive	   oxygen	   species	  
(ROS).	   These	  ROS	  potentiate	  damage	   in	  proteins,	  DNA	  and	   lipids.	   In	   this	   regard,	  RPE	  
has	  mechanisms	   of	   defence	   such	   as	   enzymatic	   and	   non-­‐enzymatic	   antioxidants	   that	  
neutralizes	  ROS	  before	  they	  can	  cause	  damage	  to	  cellular	  macromolecules	  (13,14).	  	  
	  	  	  
Bruch’s membrane 
The	   Bruch’s	   membrane	   is	   located	   between	   the	   RPE	   and	   the	   fenestrated	  
choroidal	  capillaries	  of	  the	  eye.	  It	  is	  divided	  into	  three	  layers:	  inner	  collagenous	  layer,	  
elastin	  layer	  and	  an	  outer	  collagenous	  layer.	  The	  two	  collagenous	  layers	  have	  a	  similar	  
constitution	  of	  collagen	  type	  I,	  II	  and	  V,	  organized	  in	  a	  multilayered	  grid-­‐like	  structure.	  
This	  grid	  is	  incorporated	  in	  a	  mass	  of	  interacting	  biomolecules	  like	  glycosaminoglycans.	  
The	  elastin	  layer	  is	  formed	  by	  elastin	  fibers	  of	  various	  shapes	  and	  sizes.	  Collagen	  type	  
VI,	   fibronectin	   and	   other	   protein-­‐associated	   substances	   also	   are	   part	   of	   the	   elastin	  
layer	   composition.	   The	   Bruch’s	   membrane	   regulates	   the	   diffusion	   of	   molecules	  
between	  choroid	  and	  RPE.	  Due	  to	  the	  acellular	  nature	  of	  the	  membrane,	  the	  diffusion	  
is	   regulated	   by	   passive	   processes.	   Hydrostatic	   pressure	   also	   regulates	   the	   diffusion	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through	  the	  membrane.	  Moreover,	  the	  Bruch’s	  membrane	  provides	  a	  physical	  support	  
for	  RPE	  cell	  adhesion,	  migration	  and	  differentiation	  and	  a	  division	  barrier	  for	  choroidal	  
or	  retinal	  cell	  migration	  (15).	  	  
	  
Photoreceptors (rods and cones) 
Rods	  and	  cones	  represent	  the	  two	  types	  of	  photoreceptors	  in	  the	  retina.	  They	  
are	  composed	   for	   inner	  and	  outer	   segment.	  The	   inner	  segment	  contains	   the	  nucleus	  
and	   organelles	   essentials	   for	   the	   cell	  metabolism.	   The	   outer	   segment,	   on	   the	   other	  
hand,	  is	  the	  specialized	  site	  to	  detect	  a	  photon	  signal.	  
Rods	  are	  very	  sensitive	  to	  light	  and	  respond	  to	  a	  single	  photon.	  Due	  to	  its	  high	  
light-­‐sensitivity,	   rods	   mediate	   twilight	   vision.	   Comparatively	   to	   rods,	   cones	   are	   less	  
sensitive	   to	   light	  and	  mediate	  daylight	  vision.	  Cones	   respond	   to	  on	  and	  off	  of	  a	   light	  
stimulus	   without	   significant	   delays.	   In	   this	   regard,	   we	   can	   follow	   an	   object	   moving	  
quickly	  with	  our	  eyes	  during	  daylight	  (16).	  	  
	  
1.3 Alterations of blood-retinal barrier 
The	   BRB	   has	   its	   components	   and	   their	   associated	   functions	   well	   defined.	   It	  
must	   ensure	   the	   correct	   passage	   of	   fluids	   into	   the	   retina,	   maintaining	   the	  
microenvironment	  of	  the	  retina	  and	  visual	  cells	  (17).	  Consequently,	  some	  alterations	  in	  
the	  barrier	  compromise	   its	   functions	  and	  may	   lead	  to	  the	  emergence	  of	  pathological	  
conditions.	  
Aging	   is	   associated	   with	   some	   biological	   changes	   in	   the	   eye	   mainly	   in	   the	  
Bruch’s	  membrane	  and	  RPE	  (18).	  	  
With	  age,	  the	  Bruch’s	  membrane	  alters	  its	  molecular	  composition	  and	  physical	  
properties.	   There	   is	   an	   increase	   in	   the	   collagen	   cross-­‐linking	   thereby	   increasing	   the	  
strength	  and	  density	  of	  the	  collagen	  network	  and	  consequent	  reduction	  of	  the	  Bruch’s	  
membrane	  elasticity	  and	  flexibility.	  These	  alterations	  negatively	  affect	  the	  permeability	  
of	   the	   Bruch’s	   membrane.	   Additionally,	   from	   the	   age	   of	   thirty	   on,	   the	   Bruch’s	  
membrane	   starts	   to	   calcify	   and	   therefore	   the	  membrane	   becomes	  more	   brittle	   and	  
more	   susceptible	   to	   rupture,	   allowing	   faster	   neovascularization.	   Furthermore,	   the	  
accumulation	   of	   advanced	   glycosylation	   end	   products	   (AGEs)	   on	   structural	   proteins,	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like	   the	   collagen	   in	   the	   Bruch’s	   membrane,	   inhibits	   protein	   functions	   (14).	   The	  
accumulation	  of	  AGEs	  also	   influences	  the	  production	  of	  growth	  factors,	  elevating	  the	  
production	  of	  VEGF	  and	  platelet-­‐derived	  growth	  factor	  (PDGF)	  (6).	  During	  life	  there	  is	  
also	  a	  progressive	  accumulation	  of	  lipids	  in	  the	  inner	  collagen	  layer	  forming	  a	  lipid	  wall.	  
The	   accumulation	   of	   lipids	   damages	   the	   capacity	   of	   exchange	   of	   macromolecules	  
between	  the	  choroid	  and	  the	  retina	  through	  the	  Bruch's	  membrane.	  Moreover,	  there	  
is	  an	  accumulation	  of	  basal	  deposits	  and	  drusens	  over	   life.	  Basal	  deposits,	  which	  are	  
accumulation	  of	  waste	  between	  RPE	  and	  Bruch’s	  membrane,	  can	  exist	   in	  the	  form	  of	  
basal	   laminar	   deposits	   (appear	  with	   ageing.	   It	   comprises	  mostly	   collagen	   along	  with	  
laminin,	  membrane-­‐bound	   vesicles,	   and	   fibronectin)	   and	   basal	   linear	   deposits	   (more	  
specific	   for	  AMD.	   It	   consists	   primarily	   of	   granular	   and	   vesicular	  material	  with	   foci	   of	  
wide-­‐spaced	  collagen)	  (18).	  Drusens	  are	  extracellular	  deposits	  that	  accumulate	  below	  
the	  RPE	  in	  Bruch’s	  membrane.	  Due	  to	  all	  these	  alterations,	  over	  the	  years	  the	  Bruch’s	  
membrane	  becomes	  thicker,	  varying	  from	  a	  thickness	  of	  2	  µm	  in	  the	  first	  decade	  of	  life	  
to	  approximately	  4	  to	  6	  μm	  in	  the	  tenth	  decade	  of	  life	  (19).	  	  
Lipofuscin	  is	  a	  variety	  of	  coloured	  lipid-­‐soluble	  pigments	  that	  accumulate	  in	  RPE	  
especially	  during	  ageing.	  These	  granules	  are	  not	  easily	  degradable	  and	  are	  produced	  by	  
phagocytosis	   of	   shed	   photoreceptor	   outer	   segments	   (20,21).	   Additionally,	   by	  
producing	  ROS,	  lipofuscin	  induce	  oxidative	  damage	  in	  the	  RPE	  and	  surrounding	  tissues	  
and	  inhibit	  RPE	  lysosomal	  enzyme	  activity	  (18)	  
Not	  only	  alterations	  with	  age	  but	  also	  genetic	  and/or	  environment	   influences	  
play	  a	  role	  in	  the	  alterations	  of	  BRB.	  The	  spontaneous	  photoreceptor	  cell	  loss	  can	  also	  
be	  associated	  with	  genetic	  causes	  and	  these	  can	  also	  contribute	  to	  the	  calcification	  of	  
Bruch’s	  membrane	   (14).	   Environmental	   risks	   include	   smoking,	   exposure	   to	   light	   and	  
tobacco	   smoke.	   Smoking	   leads	   to	   an	   overall	   increase	   of	   oxidative	   stress	   since	   it	   is	  
associated	   with	   the	   generation	   of	   ROS	   and	   a	   decrease	   of	   antioxidant	   capacity.	  
Moreover,	   smoking	   is	   associated	   with	   the	   formation	   of	   sub-­‐RPE	   deposits	   and	  
accumulation	   of	   deposits	   within	   the	   Bruch’s	   membrane	   (22).	   The	   light	   exposure	  
induces	  the	  formation	  of	  ROS	  and	  may	  lead	  to	  the	  formation	  of	  toxic	  lipids	  and	  protein	  
peroxidation	  products.	   The	  damage	  caused	   in	   the	  BRB	  caused	  by	   light	  exposure	  was	  
found	  to	  be	  correlated	  with	   the	  duration	  of	   the	  exposure,	   the	   light	  wavelength,	  age,	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degree	   of	   oxygenation	   of	   the	   retina,	   genetic	   factors	   and	   endogenous	   chromophores	  
(23).	  	  
The	  debris	  accumulated	  during	  ageing	  can	  cause	  an	  attraction	  of	  macrophages	  
by	   the	  dendritic	  cells	  and	  therefore	   there	  an	  autoimmune	  response	  can	  be	   triggered	  
and	  a	  consequent	  chronic	  inflammation.	  	  	  
	  	  
1.4 In vitro models of the blood-retinal barrier  
Since	  modifications	  in	  the	  BRB	  are	  associated	  with	  the	  loss	  of	  its	  functions	  and	  
a	   consequent	   appearance	   of	   pathological	   conditions	   as	   described	   in	   the	   previous	  
paragraphs,	  it	  was	  found	  to	  be	  important	  to	  study	  the	  this	  barrier	  in	  detail,	  as	  well	  as	  
understand	  the	  mechanisms	  behind	  that	  trigger	  these	  alterations	  and	  condition	  their	  
progress	  and	  outcome.	  Therefore,	  a	  number	  of	   in	  vitro	  models	  of	  the	  BRB	  have	  been	  
proposed,	   and	   found	   to	   represent	   essential	   tools	   for	   the	   study	   of	   the	   architecture,	  
barrier	  functions	  and	  regulation	  of	  the	  BRB	  but	  also	  to	  understand	  the	  consequences	  
of	  modifications	  in	  the	  BRB.	  
These	   studies	   have	   been	   developed	   with	   different	   cell	   types,	   different	  
configuration	   and	   in	   some	   cases	   some	   pathological	   conditions	   present	   in	   BRB	   have	  
been	   successfully	   simulated.	   These	   are	   discussed	   in	   more	   detail	   in	   the	   following	  
sections.	  
	  
1.4.1 BRB in vitro models involving two cell types  
Darkir	  and	  co-­‐workers	  studied	  the	  angiogenic	  profile	  of	  endothelial	  cells	  per	  se	  
in	   the	   context	   of	   the	  of	   the	  BRB	  by	   co-­‐culturing	   human	  dermal	   endothelial	   and	  RPE	  
cells	   (ARPE-­‐19,	   a	   spontaneously	   arising	   human	   RPE	   cell	   line)	   in	   direct	   and	   indirect	  
contact	  (24).	  The	  BRB	  was	  initially	  mimicked	  by	  plating	  the	  RPE	  cells	  on	  the	  bottom	  of	  
the	   plate	   and	   the	   endothelial	   cells	   on	   the	   top	   of	   a	   0,4	   µm	   Trans-­‐well	   insert	   (Figure	  
1.2A).	   As	   under	   pathological	   conditions	   the	   rupture	   of	   the	   Bruch´s	   membrane	   can	  
occur	  with	   the	  consequent	  direct	  contact	  between	  endothelial	  and	  RPE	  cells	  a	  direct	  
contact	   system	   was	   also	   proposed	   (Figure	   1.2B),	   and	   the	   pro-­‐angiogenic	   response	  
evaluated.	   This	   study	   demonstrate	   that	   the	   contact	   of	   endothelial	   and	   RPE	   cells	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induces	  the	  VEGF	  and	  matrix	  metalloproteinase-­‐2	  (MMP-­‐2)	  activity	  in	  endothelial	  cells,	  
thus	   further	   enhancing	   Bruch’s	   membrane	   degradation	   and	   promoting	   the	  




Figure	  1.2	  –	  Darkir	  and	  co-­‐workers	  proposed	  co-­‐culture	  systems.	  A	  –	  Non-­‐contact	  RPE	  and	  EC	  co-­‐culture.	  B	  –	  Direct	  
contact	  co-­‐culture.	  
	  
Kumar	  and	  co-­‐workers	  used	  human	  retinal	  progenitor	  cells	  (HRPC)	  and	  human	  
umbilical	   vein	   endothelial	   cells	   (HUVEC)	   to	   simulate	   the	   BRB.	   Two	   different	  
configurations	   were	   established	   in	   a	   0,4	   µm	   trans-­‐well	   insert,	   a	   non-­‐contact	   and	   a	  
contact	  co-­‐culture	  system	  (Figure	  1.3).	  The	  endothelial	  cells	  were	  seeded	  on	  the	  upper	  
side	   of	   the	   trans-­‐well	   and	   the	   retinal	   cells	   on	   the	   bottom	   part,	   either	   in	   the	   lower	  
chamber	  (Figure	  3A)	  or	  in	  the	  bottom	  part	  of	  the	  trans-­‐well	  (Figure	  3B).	  With	  these	  two	  
models	   the	   authors	   intended	   to	   evaluate	   the	   effect	   of	   normoxia	   and	   hypoxia.	  
Moreover,	   monolayer	   cultures	   were	   incubated	   in	   normoxia	   and	   hypoxia	   conditions	  
and	  the	  biological	  activity	  of	  conditioned	  medium	  (CM)	  was	  evaluated	  (Figure	  3C)	  (25).	  
This	  study	  shows	  that	  the	  co-­‐culture	  under	  a	  hypoxia	  environment	  resulted	  in	  a	  
synergistic	   increase	   in	   the	  expression	  of	  both	  VEGF	  and	  VEGFR-­‐2.	  Additionally,	  when	  
HRPC	  were	  treated	  with	  hypoxia	  HRPC-­‐CM,	  the	  Hypoxia-­‐inducible	  factor	  1-­‐alpha	  (HIF-­‐
1α)	   and	   nuclear	   factor	   kappa-­‐light-­‐chain-­‐enhancer	   of	   activated	   B	   cells	   (NF-­‐κB)	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Figure	  1.3	  –	  Kumar	  and	  co-­‐workers	  proposed	  co-­‐culture	  systems	  and	  monocultures.	  A	  –	  Non-­‐contact	  co-­‐culture.	  B	  –	  
Contact	   co-­‐culture.	   C	   –	  Monocultures	  with	   representation	   of	   the	   collection	   and	   addition	   of	   conditioned	  medium	  
(Adapted	  from	  (25)).	  	  
	  
Hamilton	   and	   co-­‐workers	   developed	   a	   distinct	   model	   of	   the	   BRB	   where	   they	  
mimicked	   the	   Bruch’s	   membrane	   by	   using	   an	   amniotic	   membrane	   and	   used	   a	  
minusheet	  carrier	  instead	  of	  a	  trans-­‐well	  membrane.	  The	  ARPE-­‐19	  cell	  line	  and	  HUVECs	  
were	   seeded	   in	   opposite	   sides	   of	   the	   same	  membrane	   (26).	   The	   referred	   system	   is	  
present	  in	  Figure	  1.4.	  The	  human	  amniotic	  membrane	  is	  a	  thin	  and	  elastic	  tissue	  that	  
forms	   the	   inner	   layer	   of	   amniotic	   sack.	   This	   amniotic	   membrane	   bounds	   to	   a	  
continuous	  basement	  membrane,	  which	  is	  constituted	  by	  collagen	  type	  IV	  and	  laminin,	  
and	   which	   interfaces	   with	   an	   avascular	   collagenous	   stroma	   composed	   of	   interstitial	  
collagen	  and	  elastin	  (27).	  In	  this	  regard	  it	  can	  be	  a	  substitute	  for	  the	  Bruch’s	  membrane	  
due	   to	   the	   similar	   properties.	   Moreover,	   due	   to	   its	   composition,	   human	   amniotic	  
membranes	  are	  being	  successfully	  applied	  in	  various	  fields	  of	  medicine,	  such	  as	  ocular	  
surface	  reconstruction,	  wound	  healing,	  gynaecology	  and	  tissue	  engineering	  (28).	  	  
Figure	  1.4	  –	  HUVEC	  and	  RPE	  monolayers	  separated	  by	  the	  amniotic	  membrane	  -­‐	  Transmission	  electron	  microscopy	  
(TEM)	  (Adapted	  from	  (26)).	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   The	  authors	  observed	  the	  formation	  of	  a	  continuous	  monolayer	  of	  RPE	  cells	  and	  
endothelial	  cells	  separated	  by	  a	  barrier	  of	  biological	  extracellular	  matrix.	  Despite	  some	  
degree	   of	   overlapping,	   the	   cells	   did	   not	   form	   a	  multilayer.	   Under	   co-­‐culture	   system	  
there	   was	   no	   disturbance	   in	   the	   endothelial	   adherent	   junctions	   warranted	   by	   the	  
presence	  of	  VE-­‐cadherin	  at	  cell-­‐cell	  contact.	  Additionally,	  there	  was	  also	  no	  alteration	  
in	   the	  morphology	   of	   RPE	   cells	   since	   the	   tight	   junction	   protein	   ZO-­‐1	   (ZO-­‐1)	  was	   still	  
present.	   Once	   the	   system	   was	   established	   in	   a	   minusheet	   carrier,	   it	   is	   possible	   to	  
introduce	   flow	   and	   having,	   therefore,	   a	   dynamic	   environment.	   In	   this	   way,	   the	  
permeability	   tests	   were	   performed	   under	   dynamic	   conditions.	   The	   monoculture	   of	  
ARPE	  cells	  with	  amnion	  allowed	  cell	  confluence.	  However,	  despite	  reduced	  the	  leakage	  
of	  4-­‐kDa	  traced,	  it	  did	  not	  occlude	  this	  transfer.	  On	  the	  other	  hand,	  the	  trilayer	  occlude	  
95%	   of	   the	   transfer	   of	   4-­‐kDa	   dextran	   and	   90%	   of	   the	   smaller	   sodium	   fluorescein.	  
Moreover,	  after	  3	  days	  in	  co-­‐culture,	  a	  fenestra	  appears	  in	  HUVEC,	  which	  did	  not	  occur	  
in	  monoculture,	   in	   vivo	   and	  when	  co-­‐cultured	  with	  other	   cell	   type.	   This	   alteration	   in	  
phenotype	  suggests	  that	  there	  is	  a	  RPE-­‐specific	  cross	  talk	  and	  the	  plasticity	  of	  the	  cells	  
indicating	   that	   the	   surrounding	   environment	   is	   more	   determinant	   than	   the	   site	   of	  
origin.	  	  
1.4.2 BRB in vitro models involving three cell types  
Wisniewska-­‐Kruk	   and	   co-­‐workers	   studied	   the	   contribution	   of	   pericytes	   and	  
astrocytes	   in	   the	   maintenance	   of	   BRB	   (29).	   In	   order	   to	   achieve	   their	   goal,	   they	  
established	   five	   different	   culture	   systems	   using	   primary	   cultures	   of	   bovine	   retinal	  
endothelial	   cells	   (BREC),	  bovine	   retinal	  pericytes	   (BRPC)	  and	   rat	   glial	   cells.	   Figure	  1.5	  
schematically	  represents	  the	  tested	  configurations	  systems.	  
Glial	  cells	  were	  reported	  to	  tighten	  tight	  junctions	  and	  upregulate	  and	  polarize	  
localization	   of	   specific	   blood-­‐brain	   barrier	   (BBB)	   transporters	   (30),	  which	   is	   a	   barrier	  
similar	  to	  the	  BRB.	  However,	   in	  the	  BRB,	  the	  contribution	  of	  pericytes	  and	  astrocytes	  
remains	  unknown.	  Additionally,	  under	  pathological	   conditions,	  Muller	   cells	   represent	  
the	  major	  producer	  of	  VEGF,	  compromising,	  therefore,	  the	  normal	  function	  of	  the	  BRB	  
(31).	  Under	  these	  circumstances,	  the	  authors	  proposed	  different	  configurations	  of	  BRB	  
systems	  to	  study	  the	  role	  of	  pericytes	  and	  astrocytes	  in	  the	  mainainence	  of	  BRB.	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Figure	  1.5	  –	  Wisniewska-­‐Kruk	  and	  co-­‐workers	  co-­‐culture	  systems.	  A	  –	  BRECs	  monoculture.	  B	  –	  Contact	  co-­‐culture	  
(BRECs	  and	  Glial	  astrocytes).	  C	  –	  Contact	  co-­‐culture	  (BRECs	  and	  BRPCs).	  D,	  E	  –	  Triple	  co-­‐culture	  (BRECs,	  BRPCs	  and	  
Glial	  astrocytes).	  	  
	  
The	   tightness	   of	   the	   in	   vitro	   barriers	   was	   evaluated	   by	  measuring	   the	   trans-­‐
epithelial	   resistance	   (TEER)	   values	   of	   the	   barrier.	   Comparatively	   to	   the	   BREC	  
monoculture,	  all	  the	  co-­‐cultures	  presented	  higher	  TEER	  values,	  with	  the	  highest	  value	  
being	  registered	  in	  the	  triple	  co-­‐culture	  with	  the	  astrocytes	  at	  the	  bottom	  side	  of	  the	  
insert	  and	  pericytes	  at	  the	  bottom	  of	  the	  well	  (Fig.	  5D).	  Therefore,	  this	   indicates	  that	  
the	  close	  proximity	  between	  astrocytes	  and	  BRECs	  plays	  a	  critical	  role	  in	  the	  tightening	  
of	   the	   BRB.	   Pericytes	   themselves	   do	   not	   have	   a	   direct	   influence	   in	   tightening	   the	  
barrier,	   nonetheless	   when	   placed	   on	   the	   bottom	   of	   the	   well	   and	   combined	   with	  
astrocytes	   there	   was	   a	   substantial	   increase	   of	   the	   resistance	   between	   cells.	  
Additionally	   to	   the	   tightness,	   it	  was	   also	   evaluated	   the	   permeability	   of	   the	   different	  
barriers	   and	   the	   triple	   co-­‐culture	   of	   endothelial	   cells	   in	   contact	   with	   astrocytes	   and	  
pericytes	  in	  the	  bottom	  of	  the	  well	  significantly	  reduced	  VEGF-­‐induced	  permeability	  of	  
small	  molecules.	  	  	  
 
1.4.3 General overview and discussion of the models   
Table	   1.1	   summarizes	   the	   in	   vitro	   models	   that	   were	   above-­‐mentioned	  
indicating	   the	   type	   and	   quantity	   of	   cells,	   use	   of	   an	   extracellular	  matrix	   (ECM)	   based	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Table	  1.1	  –	  Summary	  of	  the	  proposed	  BRB	  in	  vitro	  models	  proposed	  in	  the	  open	  literature.	  
Cells	   Dynamic	  
conditions	  










The	   proposed	   BRB	   in	   vitro	   models	   described	   in	   the	   open	   literature,	   with	  
exception	   of	   the	   model	   involving	   three	   cell	   types,	   were	   established	   by	   using	  
endothelial	   cells	   and	   RPE	   cells	   –	   mimicking	   the	   oBRB.	   Instead	   of	   RPE	   cells,	   the	  
Wisniewska-­‐Kruk	  and	  co-­‐workers	  established	  an	  in	  vitro	  model	  by	  using	  pericytes	  and	  
astrocytes	   aiming	   at	   a	   better	   knowledge	   of	   the	   role	   of	   these	   cells	   in	   the	   iBRB	  
maintenance.	   In	   all	   cases,	   the	   choice	  of	   endothelial	   cell	   type	   relied	  on	  primary	   cells:	  
human	   dermal	   microvascular	   endothelial	   cells,	   HUVEC	   and	   BREC.	   HUVECs	   when	  
isolated	   continue	   to	   express	   signalling	   molecules	   that	   respond	   to	   inflammatory	  
mediators,	  hypoxia	  and	  angiogenic	  growth	  factors	  (26).	  Moreover,	  this	  cell	  type	  plays	  
an	  important	  role	  as	  a	  model	  system	  in	  the	  study	  of	  the	  regulation	  of	  endothelial	  cell	  
function	  and	  the	  role	  of	   the	  endothelium	  in	  the	  response	  of	   the	  blood	  vessel	  wall	   to	  
stretch	   and	   shear	   stress	   (32).	   BRECs	   can	   be	   robustly	   sub-­‐cultured	   and	   are	   able	   to	  
maintain	  a	  stable	  phenotype	  for	  a	  long	  period	  of	  time	  (33).	  In	  these	  studies,	  the	  main	  
cell	   type	   used	   to	  mimic	   the	   RPE	  was	   the	   cell	   line	   ARPE-­‐19.	   This	   cell	   type	   is	   able	   to	  
polarize	  and	   it	  generates	  some	  characteristics	  of	  the	  barrier.	  They	  have	  already	  been	  
used	  as	  a	  model	  to	  study	  oxidative	  stress,	  retinal	  pathogenesis,	  signalling	  pathway	  and	  
toxicity	   (34).	   Kumar	   and	   co-­‐workers	   instead	   of	   a	   cell	   line	   used	   primary	   HRPCs	   cells.	  
HRPCs	  represent	  only	  0,2%	  of	  the	  pigmented	  cells	  in	  the	  ciliary	  margin	  zone.	  This	  cell	  
type	  can	  differentiate	  into	  mature	  photoreceptors	  as	  well.	  In	  order	  to	  mimic	  the	  BRB,	  
Wisniewska-­‐Kruk	  and	  co-­‐workers	  used	  primary	  cells,	  BRPCs	  and	  glial	   astrocyes.	  Their	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choice	  relies	  on	  primary	  cells	  because	  with	  these	  cells	  they	  can	  obtain	  high	  TEER	  values	  
and	  high	  expression	  of	  adherens	  and	  tight	  junctional	  complexes	  (29).	  	  
In	   the	  natural	   environment	  of	   the	   eye,	   RPE	   and	   choriocapillaries	   are	   close	   to	  
each	   other,	   only	   separated	   by	   the	   Bruch’s	  membrane.	   In	   order	   to	  mimic	   as	   well	   as	  
possible	   this	   environment,	   the	   majority	   of	   the	   in	   vitro	   models	   of	   the	   BRB	   were	  
established	  in	  a	  trans-­‐well	  insert	  with	  a	  porosity	  of	  0,4	  µm	  where	  the	  cells	  were	  seeded	  
on	  both	  sides	  of	  the	  membrane,	  having,	  therefore,	  a	  contact	  co-­‐culture	  model.	  Darkir	  
and	   co-­‐workers	  mimicked	   a	   simpler	  model,	   a	   non-­‐contact	  model,	  where	   endothelial	  
cells	  were	  seeded	  in	  the	  top	  of	  the	  trans-­‐well	  membrane	  and	  RPE	  cells	  seeded	  on	  the	  
bottom	  of	  the	  well.	  Kumar	  and	  co-­‐workers	  used	  both	  types	  of	  co-­‐cultures	  in	  order	  to	  
simulate	   the	   BRB.	   Besides	   the	   cell	   configuration,	   it	   is	   also	   important	   to	   take	   into	  
consideration	   the	   properties	   of	   the	   interface	   between	   the	   cells.	   In	   this	   perspective,	  
Hamilton	  and	  co-­‐workers	  seeded	  the	  endothelial	  and	  RPE	  cells	  on	  different	  sides	  of	  an	  
amnion	  membrane,	  which,	  as	  mentioned	  above,	  has	  similar	  properties	  to	  the	  Bruch’s	  
membrane.	  In	  a	  simpler	  way,	  Wisniewaska-­‐Kruk	  and	  co-­‐workers	  coated	  the	  trans-­‐well	  
membrane	  with	  collagen	  type	  IV,	  since	  it	  is	  one	  of	  the	  main	  components	  of	  the	  ECM.	  
Despite	   the	   permeability	   tests	   in	   the	   work	   developed	   by	   Hamilton	   and	   co-­‐
workers	   that	  were	  performed	  under	  dynamic	   conditions,	   all	   the	  models	  were	   set	  up	  
under	   static	   conditions.	   The	   static	   conditions	  however	   are	  not	   able	   to	   fully	   replicate	  
the	  in	  vivo	  environment.	  Indeed,	  cells	  are	  sensitive	  to	  their	  microenvironment,	  which	  is	  
rich	   with	   3-­‐D	   cues	   from	   the	   extracellular	   matrix,	   other	   cells	   and	   from	   mechanical	  
stimuli	   due	   to	   flow,	   concentration	   gradients	   and	  movements	   (35).	   The	   explored	   co-­‐
culture	   systems	   did	   not	   offer	   dynamic	   chemical	   or	   physical	   stimulus	   to	   cells,	   like	  
concentration	  gradients,	  flow,	  pressure	  or	  mechanical	  stress	  (36).	  	  
	  
1.5 Dynamic models – microfluidic devices  
The	  complexity	  of	  the	  physiological	  environment	  involves	  dynamic	  interactions	  
between	   cells	   and	   their	   microenvironment	   (37).	   However,	   the	   standard	   in	   vitro	  
cultures,	  microwell	  plates	  or	  petri	  dishes,	  are	  unable	  to	  introduce	  controlled	  chemical	  
concentration	  gradients	  or	  physical	  stimulus	  like	  flow	  and	  pressure	  (36,38).	  With	  this	  in	  
mind,	   various	   bioreactors	   systems	   that	   allow	   the	   culture	   of	   cells	   under	   dynamic	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conditions	   have	   been	   designed.	   Amongst	   these	   are	   low	   shear	   perfusion	   systems	   or	  
rotary	  cell	  culture	  reactors	  where	  the	  cells	  are	  subject	  to	  shear	  stresses	  and	  increased	  
nutrient	  perfusion,	  which	  positively	  influences	  cell	  function.	  Other	  bioreactor	  systems	  
emerge	   for	   tissue	   engineering	   that	   provides	   a	   high	   degree	   of	   oxygenation	   through	  
fibres	   or	  membranes,	   allowing	   adequate	   oxygen	   partial	   pressure	  with	   3-­‐dimentional	  
constructs.	   	   Lastly,	   it	   has	  been	  emerge	  a	   generation	  of	  microfluidic	   systems	   that	   are	  
becoming	   more	   general	   in	   laboratories	   and	   industries	   as	   research	   tools	   and	   are	  
especially	  suited	  to	  performing	  biological	  experiments	  (39).	  Under	  microfluidic	  devices	  
the	   laminar	   flow	   is	   easily	   established	   (40),	   the	   cells	   are	   able	   to	  maintain	   their	   own	  
microenvironment	   and	   it	   is	   possible	   to	   study	   a	   restrict	   group	   of	   cells	   by	   applying	   a	  
stimulus	   to	   that	   region	  and	  observe	   the	  response	  on	   that	  cells.	  The	  small	   size	  of	   the	  
channels	  within	  the	  microdevices	  would	  allow	  nutrients	  to	  difuse	  to	  nearby	  nutrient-­‐
poor	  areas	  (39).	  Nonetheless,	   it	   is	   important	  to	  mention	  that	  these	  devices	  also	  have	  
some	   drawbacks,	   such	   as	   the	   difficulty	   in	   predicting	   in	   vivo	   physiology	   (36).	   In	   this	  
regard,	   microfluidic	   system	   proves	   to	   be	   suitable	   to	   mimic	   the	   microenvironment	  
present	  in	  the	  BRB.	  Currently,	  there	  are	  a	  variety	  of	  microfluidic	  systems	  and	  some	  of	  
them	  are	  described	  below	  in	  more	  detail.	  	  
 
1.5.1 Multi-compartmental chamber 
The	   multi-­‐compartmental	   chamber	   (MCB)	   system	   was	   designed	   with	   the	  
purpose	   of	   mimicking	   cells	   of	   different	   organs	   or	   tissues,	   which	   are	   connected	   by	  
soluble	   ligands	   through	  blood,	   lymph,	  or	  other	   fluids	   in	   the	  extracellular	  matrix	   (40).	  
Mazzei	  et	   al.	   (41)	   proposed	   the	  MCB	  bioreactor	   (figure	   1.6)	   to	   simulate	   a	  metabolic	  
system	   where	   two	   different	   compartmental	   cell	   culture	   chambers	   were	   assembled.	  
The	  first	  unit	  mimics	  the	  cardiovascular	  system,	  in	  which	  shear	  stress	  and	  hydrostatic	  
pressure	   can	   be	   applied.	   	   The	   second	   unit	   simulates	   the	  metabolic	   system	   and	   the	  
chambers	  with	  different	  cell	  types	  are	  cultured	  in	  parallels	  or	  series.	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Figure	  1.6	  –	  MCB	  	  bioreactor.	  A	  -­‐	  MCB	  chamber	  topological	  scheme	  (Adapted	  from	  (41)).	  B	  –	  The	  MCB	  bioreactor	  
before	  assembly,	  showing	  the	  liver,	  pancreas,	  and	  target	  tissue	  compartments	  (40).	  	  	  	  	  	  
	  
1.5.2 Multi-Compartmental modular bioreactor 
The	  multi-­‐compartmental	  modular	  bioreactor	  (MCmB)	  system	  is	  composed	  of	  a	  
cell	  culture	  chamber	  that	  can	  be	  linked	  to	  other	  chambers	  in	  parallel	  or	  in	  series.	  In	  this	  
manner	   it	   is	   possible	   to	   mimic	   different	   biological	   systems.	   The	   MCmB	   presents	  
important	   advantages	   in	   comparison	   to	   the	   MCM	   system	   where	   there	   are	   a	   fixed	  
number	   of	   compartments.	   Thus,	   the	   MCmB	   arose	   as	   an	   evolution	   of	   MCB	   system	  
(36,40).	  	  	  
In	  the	  first	  attempt	  to	  build	  this	  model,	  some	  problems	  emerged	  leading	  to	  the	  
formation	   of	   bubbles	   in	   the	   top	   of	   the	   chamber	   affecting	   the	   flow	   profile	   and	  
consequently	   causing	   turbulence	   and	   unknown	   values	   of	   shear	   stress.	   To	   solve	   this	  
problem,	  some	  alterations	  were	  introduces	  in	  the	  bioreactor.	  Namely,	  increase	  of	  the	  
diameter	  of	  the	  chamber	  (from	  13	  mm	  to	  15	  mm),	  use	  of	  an	  outlet	  tube	  with	  a	  larger	  
diameter	  	  (from	  1	  mm	  to	  2	  mm)	  and	  the	  introduction	  of	  a	  slope	  in	  the	  top	  surface	  of	  
the	  upper	  chamber	  (36).	  Figure	  1.7	  represents	  this	  system.	  	  
	  	  	  	  Vinci	  et	  al.	   (42)	   seeded	   isolated	  hepatocytes	   from	  12	  different	   liver	  donors	  
into	  MCmB	  connected	  chambers.	  The	  authors	  submitted	  primary	  human	  hepatocytes	  
to	  culture	  medium	   flow,	  mimicking	   the	  blood	   flow	   in	   the	   liver.	  The	  presence	  of	   flow	  
specifically	   interferes,	   and	   up-­‐regulate,	   with	   the	   activity	   of	   xenosensors	   and/or	  
expression	   of	   detoxification	   genes	   in	   primary	   human	   hepatocytes.	   Under	   static	  
conditions,	   there	   is	   a	   down-­‐regulation	   of	   detoxification	   genes	   probably	   due	   to	   the	  
absence	  of	  medium	  circulation.	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Figure	  1.7	  –	  MCmB	  systems.	  	  A	  –	  MCmB	  bioreactor	  chambers	  (36).	  B	  –	  Assemble	  of	  MCmB	  bioreactors	  systems.	  	  	  	  
	  
1.5.3 Laminar flow chamber 
The	  laminar	  flow	  chamber	  (LFC),	  represented	  in	  figure	  1.8	  was	  designed	  aiming	  
at	  applying	  a	  uniform	  wall	  shear	  stress,	  which	  is	  found	  in	  the	  human	  vascular	  system.	  
The	  purpose	  of	   this	  set-­‐up	   is	  also	  to	  minimize	  the	   internal	  volume	  of	   the	  cell	  culture	  
chamber,	  by	  reducing	  the	  volume	  of	  culture	  medium,	  and	  obtain	  an	  area	  similar	  to	  the	  
standard	  ones	  found	  in	  12	  or	  24	  multi-­‐well	  plates.	  Additionally,	  it	  allows	  the	  placing	  of	  
the	  chamber	  in	  a	  regular	  microscope	  stage	  and	  reduces	  recirculation	  regions	  near	  the	  
active	   zone	   for	   cell	   culture	   (36).	   This	   system	   was	   used	   by	   Vinci	   et	   al.	   (37)	   to	   seed	  
HUVECs.	   These	   authors	   proved	   that	   the	   application	   of	   dynamic	   conditions	   on	   the	  
culture	  of	  HUVECs	  had	  an	  impact	  on	  their	  metabolic	  profile	  by,	  for	  example,	  increasing	  
the	  glucose	  uptake	  levels.	  	  	  	  
	  
Figure	  1.8	  –	  LFC	  bioreactor.	  A	  –	  The	  LFC	  dissembled	  showing	  the	  two	  halves	  and	  the	  aluminum	  frame	  (36).	  B	  –	  The	  
assembled	  LFC	  (36).	  	  
	  
Vinci	   and	   co-­‐workers	   (35)	   connected	   the	   LCF	   system	  with	   the	  MCmBs	   (figure	  
1.9)	   in	   order	   to	   investigate	   the	   metabolic	   cross-­‐talk	   between	   HUVECs	   and	   adipose	  
tissue	  and	  the	  role	  of	  hepatocytes	  in	  regulating	  circulating	  metabolites.	  While	  hepatic	  
cells	  and	  adipose	   tissue	  were	  cultured	   in	   the	  MCmB	  2.0	  chambers	  and	  consequently	  
subjected	   to	   low-­‐shear	   stress,	   HUVECs	   were	   seeded	   on	   the	   LFC	   chamber.	   The	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chambers	  were	  connected	  in	  a	  closed	  loop.	  With	  this	  model,	  it	  was	  possible	  to	  observe	  
physiological	  systemic	  processes,	  like	  glucose	  and	  lipid	  metabolism.	  
Figure	   1.9	   –	  McmB	   and	   LFC	   connected	   systems.	   A	   –	   Experimental	   set	   up	   (35).	   B	   –	   Connection	   scheme	   showing	  
chamber	  dimensions	  in	  mm	  (35).	  	  
	  
1.6 Aim of the thesis  
In	   vitro	   models	   of	   the	   BRB	   represent	   essential	   tools	   for	   the	   study	   of	   eye	  
pathological	  conditions	   like	  AMD.	  Since	  dynamic	   in	  vitro	  models	  can	   incorporate	  and	  
mimic,	  not	  only	   the	  biochemical	  environment,	  but	  also	   the	  physical	   stimuli	   that	  cells	  
are	  subjected	  to	  in	  vivo,	  they	  provide	  a	  better	  tool	  to	  simulate	  in	  vitro	  the	  environment	  
found	   in	   vivo	   comparatively	   to	   static	   in	   vitro	   models.	   Although	   nowadays	   it	   is	  
recognized	   their	   importance,	   there	   is	   not	   a	   dynamic	   in	   vitro	   model	   for	   the	   BRB.	  
Microfluidic	   devices	   have	   emerged	   as	   dynamic	   in	   vitro	   models	   and	   represent	   an	  
optimal	  system	  to	  mimic	  the	  BRB	  since	  it	  is	  possible	  to	  introduce	  different	  stimulus	  and	  
observe	  their	  consequences	  in	  a	  small	  group	  of	  cells.	  Therefore	  the	  aim	  of	  the	  thesis	  is	  
to	   use	   a	   barrier	   system,	   which	   resembles	   the	   BRB	   conditions	   under	   a	   static	   and	  
dynamic	  environment,	  to	  test	  new	  therapeutic	  agents	  (in	  the	  context	  of	  this	  thesis	  TiO2	  
based	   biomaterials	   were	   assessed)	   for	   the	   treatment	   of	   AMD.	   The	   dynamic	  
environment	   will	   be	   implemented	   in	   a	   bioreactor	   previously	   developed	   in	   Pisa	  
University	   (Italy).	   Since	   the	   retina	   is	   highly	   susceptible	   to	  oxidative	   stress	   created	  by	  
the	   cellular	   unbalance	   between	   production	   and	   degradation	   of	   ROS,	   its	   excess	   has	  
been	   associated	   with	   the	   onset	   and	   progression	   of	   AMD.	   So	   the	   TiO2	   based	  
biomaterials	   are	   envisaged	  as	  ROS	   scavengers	   and,	   consequently,	   to	  be	  used	   to	  halt	  
the	  progression	  of	  this	  illness.	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1.6.1 Age-related macular degeneration (AMD)   
AMD	   is	   a	   progressive	   disease	   and	   a	   leading	   cause	   of	   blindness	   and	   visual	  
disability	  over	  the	  age	  of	  50	  years	  in	  industrial	  societies.	  (18,43).	  This	  disease	  develops	  
slowly	  and	  asymptomatically	  in	  the	  first	  years	  (44).	  Progressively	  the	  patients	  start	  to	  
lose	  central	  vision	  making	  simple	  tasks	  like	  reading	  a	  book	  or	  driving	  a	  true	  challenge	  
(43).	   Regarding	   the	   progress	   of	   AMD,	   it	   is	   possible	   to	   divide	   this	   pathology	   into	   an	  
asymptomatic	   early	   stage,	   and	   late	   stage	  AMD,	  where	   vision	   loss	   occurs.	   In	   the	   late	  
stage	   of	   AMD	   it	   can	   be	   subdivided	   into	   the	   “dry”	   and	   “wet”	   forms	   (43,44),	  
characterized	   either	   by	   the	   absence	   or	   presence	   of	   choroidal	   neovascularization,	  
respectively	  (45).	  Figure	  1.10	  shows	  the	  different	  stages	  of	  the	  disease.	  	  
Despite	  some	  treatments,	  currently	  there	  is	  no	  way	  of	  curing	  or	  preventing	  this	  
form	   of	   degeneration.	   Nevertheless,	  with	   the	   current	   knowledge	   about	   the	   disease,	  
different	   strategies	   were	   developed.	   Since	   oxidative	   damage	   is	   associated	   with	   the	  
progression	   of	   the	   disease,	   an	   antioxidant	   therapy	  may	   play	   a	   role	   in	   reduction	   the	  
disease	   progression.	  With	   this	   point	   of	   view,	   some	   clinical	   trials	   prove	   that	   the	   oral	  
administration	  of	  an	  antioxidant	  combination	  like	  vitamic	  C,	  vitamic	  E,	  beta	  carotene,	  
zince	  oxide	  and	  cupric	  oxide	  had	  a	  25	  %	  relative	  risk	  of	  developing	  advanced	  AMD	  in	  
the	  other	  eye	  (46).	  Nevertheless,	  other	  study	  demonstrate	  that	  oral	  administration	  of	  
antioxidants	   mainly	   beta	   carotene	   increases	   the	   risk	   of	   lung	   cancer	   (47).	  When	   the	  
disease	   is	   in	  a	   later	  stage	   is	  characterized	  by	  the	  choroidal	  neovascularization,	   in	  this	  
regard	   the	   treatments	   are	   associated	   with	   stopping	   the	   progression	   and	   aid	   in	   the	  
regression	  of	  choroidal	  neovascularization.	  One	  of	  the	  first	  treatments	  in	  this	  field	  was	  
the	  laser	  photocoagulation,	  which	  reveals	  efficacy	  in	  patients	  with	  a	  very	  well	  defined	  
choroidal	  neovascularization	  (48).	  However,	  as	  a	  destructive	  therapy	  intervention,	  the	  
patients	  who	  underwent	  this	  treatment	  may	  develop	  atrophic	  scars.	  As	  an	  alternative	  
to	   this	   treatment,	   it	   was	   develop	   a	   photodynamic	   therapy	   with	   verteporfin.	   This	  
treatment	   is	  composed	  by	  two	  phases.	  The	  first	  one	  concernes	  the	  administration	  of	  
the	  pharmacologic	  photo	  sensitizer	  intravenously	  followed	  by	  an	  activation	  with	  a	  laser	  
that	  has	  the	  same	  wavelength	  of	   light	  absorption	  as	  the	  drug.	  The	  results	  shows	  that	  
the	  therapy	  reduces	  the	  risk	  of	  vision	  loss	  but	  the	  improvement	  of	  vision	  is	  rare	  (49).	  
Another	   strategy	   for	   the	   treatment	   of	   later	   AMD	   concerns	   to	   an	   anti-­‐VEGF	   therapy.	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Several	  targeting	  agents	  have	  been	  tested.	  	  Pegaptanib	  (Macugen®)	  emerge	  as	  the	  first	  
drug	  approved	   for	   that	  propose,	  however	   it	   this	   treatment	   is	  also	  accompanied	  by	  a	  
loss	   of	   vision	   acuity	   (50).	   Following	   the	   same	   strategy,	   other	   anti-­‐VEGF	   drugs	   were	  
developed	  and	  approved	  like	  ranibizumab	  (Lucentis®)	  (51)	  and	  bevacizumab	  (Avastin®)	  
(52).	   Despite	   the	   evolution	   in	   the	   treatments	   of	   AMD,	   a	   number	   of	   challenges	   and	  
clinical	  questions	  remain.	  	  
	  
	  
Early age-related macular degeneration  
Early	  AMD,	  in	  a	  patient's	  perspective,	  is	  hardly	  symptomatic.	  Nevertheless,	  from	  
a	   clinical	   point	   of	   view,	   it	   is	   characterized	   by	   drusens	   or	   by	   hyperpigmentations	   or	  
small	   hypopigmentations,	   without	   visible	   choroidal	   vessels	   (23,43).	   Drusens	   are	   the	  
formed	  deposits	  between	  the	  RPE	  and	  Bruch’s	  membrane.	  They	  can	  be	  small,	  appear	  
flat	  and	  be	  well	  circumscribed	  or	  poorly	  defined	  and	  then	  can	  be	  called	  as	  hard	  or	  soft,	  
respectively.	  Hard	  drusen	  appear	  hyaline	  in	  cross	  section,	  may	  have	  a	  central	  core	  that	  
can	   contain	   a	   dentritic	   cell	   process	   extending	   from	   a	   cell	   with	   its	   perikaryon	   in	   the	  
choroid	  proper,	  and	  have	  well-­‐defined	  edges.	  They	  also	  are	  more	  prevalent	  outside	  the	  
macula	   proper	   and	   arise	   most	   frequently	   between	   capillaries	   in	   the	   subjacent	  
choriocapillaries.	   On	   the	   other	   hand,	   soft	   drusens	   have	   poorly	   defined	   edges	   and	  
appear	  more	  heterogeneous	  (43).	  	  
	  
Late age-related macular degeneration  
Late	  AMD	  is	  characterized	  by	  two	  different	  forms,	  “dry”	  and	  “wet”.	  These	  two	  
distinct	  forms	  can	  appear	  in	  the	  same	  patient	  in	  different	  eyes	  or	  even	  in	  the	  same	  eye	  
(23).	   The	   pathophysiologies	   of	   “dry”	   and	   “wet”	   forms	   are	   somehow	   overlapping,	  
however,	  they	  are	  clinically	  different	  since	  the	  treatments	  are	  different	  (45).	  	  
Physically,	  “dry”	  AMD,	  which	  is	  also	  called	  geographic	  atrophy,	  is	  characterized	  
by	  a	  retinal	  despigmentation	  area	  where	  choroidal	  vessels	  are	  visible	  and	  there	   is	  no	  
neovascularization	  (23,44).	  The	  core	  of	  dry	  AMD	  is	  the	  degeneration	  of	  areas	  from	  the	  
RPE	  (43,44).	  Loss	  of	  photoreptors	  and	  choriocappilaries	  occurs.	  Moreover,	  there	  is	  an	  
accumulation	   of	   lipofuscin,	   which	   can	   interfere	   with	   RPE	   lysosomal	   function	   and	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consequently	   increase	  autophagy	  (43).	  Despite	  the	  presence	  of	  drusens,	  they	  are	  not	  
sufficient	  to	  break	  the	  Bruch’s	  membrane.	  	  	  	  	  	  	  	  
“Wet”	   AMD,	   also	   referred	   as	   neovascular	   AMD,	   is	   characterized	   by	   choroidal	  
neovascularization,	  where	  new	  immature	  blood	  vessels	  grow	  towards	  the	  outer	  retina,	  
leading	  to	   leakage	  of	  fluid	  below	  or	  within	  the	  retina	  (44,45).	  The	  fluid	   is	  responsible	  
for	   the	   formation	   of	   a	   neovascular	  membrane	   (23).	   The	   photoreceptor	   loss	   is	  more	  
severe	   comparatively	  with	   dry	  AMD	   (46).	   If	   left	   untreated,	  wet	  AMD,	   causes	   central	  
vision	   loss	   (18,23).	   Patients	   with	   subfaveolar	   choroidal	   neovascularization	   develop	  
profound	  central	  vision	  loss	  regardless	  of	  whether	  the	  choroidal	  neovascularization	  has	  
a	  classical	  or	  occult	  morphologic	  feature	  on	  angiography	  (18).	  	  	  	  	  
Figure	  1.10	  –	  Fundus	  photographs	  representing	  different	  stages	  of	  AMD.	  A	  –	  Normal	  right	  eye.	  B	  –	  Early	  AMD	  where	  
large	   drusens	   can	   be	   seen	   (multiple	   yellowish	   clumps).	   C	   –	   Early	   AMD	   where	   it	   is	   possible	   to	   observe	   pigment	  
irregularities.	  An	  area	  of	  hyperpigmentation	  and	  hypopigmentation	  can	  be	  seen	  just	  temporal	  to	  the	  centre	  of	  the	  
macula.	  D	  –	  Late	  AMD,	  “dry”	  AMD,	  there	   is	  an	  extensive	  area	  of	  sharply	  demarcated	  RPE	  atrophy.	  E	  –	  Late	  AMD,	  
“wet”	  AMD,	  where	  there	  is	  a	  growth	  of	  blood	  vessels	  and	  form	  a	  neovascular	  membrane.	  It	  is	  possible	  to	  observe	  
within	  the	  image	  the	  consequent	  haemorrhage.	  F	  –	  Late	  AMD,	  formation	  of	  a	  scar	  tissue	  (47).	  
	  
1.6.2 Oxidative stress and reactive species of oxygen  
As	  previously	   stated,	   the	   retina	   is	  one	  of	   the	  most	  metabolic	  active	   tissues	   in	  
the	   body	   having	   a	   high	   rate	   of	   oxygen	   consumption.	   Consequently	   it	   is	   more	  
susceptible	  to	  oxidative	  damage	  caused	  by	  the	  generation	  of	  ROS.	  In	  order	  to	  prevent	  
or	   diminish	   the	   negative	   effects	   of	   oxidative	   stress,	   the	   cells	   developed	   different	  
protective	  mechanisms	  (48,49).	  Therefore,	  a	  situation	  of	  oxidative	  stress	  only	  develops	  
when	   there	   is	   an	  overproduction	  and	  an	   insufficient	  elimination	  of	  ROS	   (50).	  Briefly,	  
ROS	   are	   diffusible	   and	   highly	   active	   molecules.	   Free	   radicals,	   hydrogen	   peroxide	   or	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singlet	  oxygen	  are	  examples	  of	  ROS	  (50).	  Cells	  can	  produce	  ROS	  intracellulary	  with	  the	  
purpose	   of	   protecting	   against	   infection	   agents	   and	   redox-­‐sensitive	   signalling	  
transduction	  (51)	  Nonetheless,	  once	  ROS	  are	  extracellular	  released,	  they	  can	   interact	  
with	  O2	  or	  other	  compounds	  and	  be	  involved	  in	  oxidative	  processes	  (50,51).	  There	  are	  
several	  sources	  of	  ROS	  in	  the	  retina.	  Mitochondria	  are	  a	  major	  source	  of	  endogenous	  
ROS	  and	  the	  existing	  cross-­‐talk	  with	  NADPH	  oxidase,	  can	  represent	  a	  “vicious	  cycle”	  of	  
ROS	  production.	  Mitochondria	   represent	   a	   target	   for	  NADPH	  oxidase-­‐generated	  ROS	  
and	  mitochondrial	  ROS	  under	  certain	  conditions	  may	  stimulate	  NADPH	  oxidases.	  Light	  
is	   essential	   for	   vision,	   however	   it	   can	   lead	   to	   the	   photogeneration	   of	   ROS	   and	  
consequently	  cause	  photochemical	  damage	  to	  the	  retina	  (48).	  The	  exposition	  to	   light	  
or	   in	   particular	   to	   blue	   light	   leads	   to	   the	   production	   of	   singlet	   oxygen	   due	   to	  
photosensitisation	  of	  the	  macula.	  The	  wavelength	  of	  the	  light	  is	  intimately	  related	  with	  
the	   amount	   and	   type	   of	   free	   radicals.	   Thus,	   singlet	   oxygen	   can	   attach	   to	   the	  
membranes	   and	   other	   cell	   components	   mainly	   photoreceptor	   outer	   segments	   (50).	  
Furthermore,	   alcohol	   consumption	   and	   smoking,	   including	   tobacco	   smoke,	   are	  
exogenous	   sources	   of	   oxidative	   stress.	   Alcohol	   consumption	   enhances	   ROS	   levels,	  
leading	  to	  DNA,	  protein	  and	  lipid	  oxidation.	  The	  cigarette	  smoke	  is	  associated	  with	  the	  
increase	   in	   oxidative	   stress	   by	   the	   generation	   of	   ROS	   or	   reduction	   of	   antioxidant	  
capacity	   (48).	  As	  mentioned	  above,	   there	  are	  several	  mechanisms	  of	  defence	  against	  
oxidative	  stress	   in	  order	   to	  create	  an	  equilibrium	  state	  between	  ROS	  production	  and	  
elimination.	  Table	  1.2	  resumes	  some	  of	  those	  mechanisms:	  	  	  
	  
Table	  1.2	  –	  Biologic	  mechanisms	  to	  protect	  the	  cells	  against	  oxidative	  stress	  	  
Cellular	  
compartmentalization	  
ROS	  are	  separated	  from	  cellular	  components	  that	  are	  susceptible	  to	  
oxidative	  damage	  
Enzymatic	  antioxidants	   Superoxide	  dismutase,	  catalase	  and	  glutathione	  peroxidase	  
represent	  the	  majority	  of	  them	  	  
Non-­‐enzymatic	  
antioxidants	  
Vitamins	  C,	  E,	  and	  certain	  carotenoids	  react	  directly	  an	  in	  a	  
nonenzymatic	  way	  with	  ROS	  producing	  harmless	  products	  and	  
terminating	  the	  free	  radical	  chain	  reaction	  	  
DNA	  repair	   Replacement	  of	  DNA	  portion	  that	  was	  distorted	  by	  action	  of	  DNA	  
polymerase	  and	  closed	  by	  the	  action	  of	  a	  ligase	  
Some	   factors	   like	   aging,	   environmental	   influences	   and	   genetic	   susceptibilities	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intracellular	  oxidizing	  agents	  accompanied	  by	  a	  decrease	  in	  cell’s	  defence	  mechanisms	  
(52).	  	  
The	  oxidative	  stress	  contributes	  to	  RPE	  dysfunction	  and	  lead	  to	  the	  entrapment	  
of	   abnormal	   proteins	  within	   the	   Bruch’s	  membrane.	   Since	   RPE	   cells	   play	   a	   principal	  
role	   in	   the	   immune	   defence	   of	   macula,	   this	   may	   lead	   to	   autoimmune-­‐mediated	  
inflammation	  (43,53).	  Hence,	  there	  is	  a	  link	  between	  oxidative	  stress	  and	  inflammatory	  
system	   and	   to	   observe	   this	   link,	   Kauppinen	   and	   co-­‐workers	   examined	   if	   under	  
oxidative	   stress	   conditions,	   the	   ARPE-­‐19	   cell	   line	   activates	   the	   inflammasome	  
signalling.	  Briefly,	  lipid	  peroxidation	  end-­‐product	  4-­‐hydroxynonenal	  (HNE),	  significantly	  
increases	   the	   quantity	   of	   NLRP-­‐3-­‐specific	   mRNA	   in	   ARPE-­‐19	   cells.	   Innate	   immune	  
system	  monitors	   cellular	   stress	   factors	   through	   pattern	   recognition	   receptors	   (PRRs)	  
and	   non-­‐like	   receptors	   (NLR),	   which	   are	   the	   sensing	   components	   of	   inflammasome	  
complex.	  The	   inflammasome	  complexes	  best	  known	  are	   the	  NLRP-­‐3	   inflammasomes.	  
Moreover,	   HNE-­‐treated	   cells	   produce	   pro-­‐inflammatory	   cytokines	   like	   Interleukin-­‐1	  
beta	  (IL-­‐1β)	  and	  Interleukin-­‐18	  (IL-­‐18)	  (53).	  	  	  
	  	  	  
1.6.3 Inflammation in AMD 
The	   defence	   mechanisms	   in	   the	   human	   body	   fall	   into	   different	   categories.	  
There	   is	   a	   first	   line	   of	   defence	   involving	   a	   physical	   barrier,	   like	   skin,	   preventing	   the	  
entry	   of	   pathogens;	   there	   is	   also	   a	   second	   line	   of	   defence	   that	   involves	   the	   innate	  
immune	  system	  and	   includes	  complement	  and	   inflammatory	  cells	   (macrophages	  and	  
recruited	  leukocytes);	  in	  addition	  there	  is	  a	  third	  line	  of	  defence	  involving	  an	  adaptive	  
immune	  system	  that	  includes	  clearance	  of	  altered	  pathogens	  and	  tissue	  repair	  (54).	  	  
In	   the	   retina,	  microglia	   represent	   the	   resident	   inflammatory	   cells.	   These	   cells	  
are	  similar	   to	   the	   tissue	  macrophages	  and	   the	  central	  nervous	  system	  microglia.	  The	  
sub-­‐retinal	  migration	  of	  microglia	  plays	  an	   important	  role	   in	   the	  elimination	  of	  visual	  
by-­‐products	   and	   is	   essential	   for	   vision	   maintenance	   (55).	   On	   the	   other	   hand,	  
macrophages	   can	   endocytose	   and	   remove	   advanced	   AGEs,	   which	   accumulates	   in	  
Bruch’s	   membrane	   throughout	   life	   and	   can	   increase	   the	   secretion	   of	   VEGF.	  
Macrophages	   can	   also	   remove	   the	   apoptotic	   cell	   debris	   and	   limit	   inflammation	   by	  
inhibiting	  the	  production	  of	  inflammatory	  cytokines	  (56).	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An	   improper	   activation	   of	   immune	   cells,	   also	   play	   a	   role	   in	   the	   AMD	  
progression.	   In	   fact,	   in	   AMD	   pathology,	   the	  microglia	   accumulates	   in	   the	   subretinal	  
space	   reflecting	   a	   sign	   of	   inflammation	   damage	   and	   intensified	   retinal	   degeneration	  
(55).	  On	  the	  other	  hand,	  macrophages	  are	  present	  in	  the	  neovascular	  membrane	  and	  
express	   pro-­‐angiogenic	   cytokines	   like	   VEGF,	   which	   indicates	   that	   macrophages	  
promote	   an	   excessive	   endothelial	   cell	   growth	   in	   choroidal	   neovascularization.	   In	  
addition	  to	  pro-­‐angiogenic	  proteins,	  macrophages	  can	  also	  secrete	  ROS.	  Furthermore,	  
these	   cells	   play	   an	   important	   role	   in	   extracellular	   matrix	   turnover	   and	   express	   a	  
number	  of	  matrix	  metalloproteases	  that	  could	  lead	  to	  Bruch’s	  membrane	  breakdown	  
(56).	  	  
Along	  with	  macrophages,	  dendritic	  cells	  are	  normally	  present	  in	  the	  retina	  but	  
reside	   in	   the	  underlying	   choroid.	  Nevertheless,	   in	   cases	  of	   breakdown	  of	   the	  blood–
retinal	   barrier,	   these	   cells	   are	   recruited	   from	   the	   underlying	   choroid	   or	   from	   the	  
systemic	  and	  accommodate	  in	  the	  retina	  where	  they	  modulate	  the	  disease	  (55).	  This	  is	  


















Figure	  1.11	  –	  Retinal	  anatomy	  in	  health	  and	  disease	  (55).	  	  	  
Concluding	  and	  in	  accordance	  with	  that	  described,	  the	  work	  plan	  for	  my	  thesis	  
can	  be	  divided	  into	  three	  main	  goals.	  Firstly,	  evaluated	  the	  ROS	  scavenging	  capacity	  of	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different	  calcined	  titanium	  dioxide	  (TiO2)	  powders	  using	  artificial	  ROS.	  Once	  chemically	  
evaluated	  the	  ROS	  scavenging	  capacity	  of	  the	  different	  powders,	  the	  next	  step	  was	  to	  
use	  ROS	  produced	  by	  macrophages	  to	  analyse	  the	  ROS	  scavenging	  capacity	  of	  the	  most	  
promising	  TiO2	  powders.	  Completed	  this	  part	  of	  the	  work,	  the	  goal	  was	  to	  implement	  a	  
dynamic	  system,	  using	  a	  microfluidic	  device.	  This	  system	  was	  used	  to	  test,	  chemically,	  
the	  permeability	  to	  the	  ROS	  species	  and	  further	  the	  macrophages	  were	  seeded	  on	  the	  
membrane	   and	   similar	   tests	   were	   performed.	   This	   work	   is	   part	   of	   the	   BIOAMD	   –	  
biomaterials	   for	   modulation	   of	   inflammation	   in	   Age-­‐related	   macular	   Degeneration	  
project	   that	   is	   in	   collaboration	  with	   the	   Instituto	  de	  Cerámica	   y	  Vidrio	   del	   CSIC	   from	  
Spain	   and	   the	   University	   of	   Pisa	   in	   Italy.	   The	   main	   aim	   is	   to	   create	   an	   implant	  
biomaterial	   using	   TiO2	   and	   poly(methyl	   methacrylate)	   (PMMA)	   as	   a	   substrate.	   This	  
biomaterial	   needs	   to	   be	   able	   to	   modulate	   the	   extracellular	   microenvironment	   and	  
connective	   tissue	   of	   the	   eye	   in	   order	   to	   prevent	   and	   control	   those	   inflammatory	  
processes	  that	  occur	  during	  the	  progression	  of	  the	  disease.	  In	  this	  regard,	  the	  different	  
used	  TiO2	  powders	  were	  produced	  and	  provided	  by	  the	  CSIC	  and	  the	  used	  bioreactor	  
systems	  were	  produced	  and	  provided	  by	  the	  University	  of	  Pisa.	  	  
Titanium	   is	   a	   widely	   used	   biomaterial.	   Its	   biocompatibility	   is	   due	   to	   the	   thin	  
surface	   oxide	   layer	   –	   predominantly	   TiO2	   –	   of	   approximately	   4	   nm	   that	   is	  
spontaneously	  formed	  when	  titanium	  is	  exposed	  to	  air	  or	  oxygen	  containing	  solutions	  
(57).	  	  
TiO2	  is	  a	  semiconductor	  and	  when	  absorbs	  a	  photon	  of	  light	  with	  energy	  above	  
its	   valence	   band	   gap,	   an	   electron	   from	   the	   valence	   band	   can	   be	   excited	   to	   the	  
conduction	  band	  yielding	  an	  electron-­‐hole	  pair	  (e-­‐/h+)	  and	  consequently	  is	  exhibited	  an	  
potent	   redox	   activity.	   Various	   species,	   including	   hydrogen	   peroxide	   (H2O2),	   hydroxyl	  
radical	  (HO.)	  and	  hydroperoxyl	  radical	  (HOO.)	  appear	  in	  the	  irradiated	  TiO2	  surface	  (58).	  
On	  the	  other	  hand	  the	  presence	  of	  titanium	  dioxide	  coatings	  is	  helpful	  in	  the	  mitigation	  
of	   the	   inflammatory	   response	   due	   to	   the	   catalytically	   breaking	   down	   of	   ROS	   like	  
hydrogen	   peroxide,	   superoxide	   and	   peroxynitric	   at	   physiological	   pH	   (59).	   The	  
neutralization	  of	  ROS	  occurs	  due	  to	  chemical	  reactions	  that	  involve	  reversible	  changes	  
in	  Ti	  valence	  and	  allow	  to	  synthesize	  oxides	  with	  enhance	  anti-­‐inflammatory	  properties	  
(60).	  	  
   Introduction 27 
	  
Master in Biomedical Engineering 2013/2014 
	  
There	   are	   three	  main	   crystalline	   phases	   of	   TiO2,	   anatase,	   rutile	   and	  brookite,	  
which	   differ	   in	   their	   physicochemical	   behaviour.	   Rutile	   is	   the	   most	   stable	  
thermodynamically	  (60).	  On	  the	  other	  hand,	  anatase	  and	  brookite	  are	  metastable	  and	  
they	  can	  be	  transformed	  into	  the	  rutile	  phase	  by	  heating	  treatment	  above	  450°C.	  The	  
transformation	  from	  anatase	  to	  rutile	  occurs	  from	  400°C	  to	  1200°C,	  depending	  on	  the	  
grain	   size,	  presence	  of	   impurities,	  dopants,	  precursor	  material	  and	  synthesis	  method	  
(61).	   As	   the	   calcination	   temperature	   increases,	   the	   particle	   size	   also	   increases	   and	  
contrasting	   the	   corresponding	   surface	   area	   decreases	   (62,63).	   Moreover,	   a	   larger	  
surface	  area	   is	   capable	   to	  elicit	  more	   cytotoxic	  and	  phototoxic	  effects	   comparatively	  
with	  smaller	  surface	  area	  (62).	  The	  TiO2	  band	  gaps	  goes	  from	  3,0	  eV	  in	  the	  case	  of	  pure	  
rutile	  to	  3,2	  eV	  in	  the	  case	  of	  pure	  anatase	  (64).	  	  
In	   order	   to	   further	   explore	   the	   different	   properties	   of	   the	   powders	   the	  
collaborating	   group	   from	   CSIC	   developed	   different	   calcined	   TiO2	   powders	   and	   their	  
properties	  are	  mentioned	  in	  the	  following	  tables	  (Table	  1.3	  and	  1.4).	  	  
Table	  1.3	  –	  Summary	  of	  the	  physical	  and	  crystallochemical	  characterization	  of	  the	  powders:	  %	  anatase,	  %	  rutile	  and	  
%	  crystallinity.	  	  
	  
SAMPLE	   %	  ANATASE	   %	  RUTILE	   %	  CRYSTALLINITY	  
TIO2	  200°C	   100%	   0%	   50	  
TIO2	  400°C	   100%	   0%	   75	  
TIO2	  600°C	   77%	   23%	   100	  
TIO2	  650°C	   13%	   87%	   -­‐-­‐-­‐	  
TIO2	  700°C	   3%	   97%	   -­‐-­‐-­‐	  
TIO2	  750°C	   2%	   98%	   -­‐-­‐-­‐	  
TIO2	  COMMERCIAL	  
204757	  
6%	   94%	   -­‐-­‐-­‐	  
	  
Table	  1.4	  –	  Summary	  of	   the	  physical	  and	  crystallochemical	  characterization	  of	   the	  powders:	  specific	  surface	  area,	  
particle	  size	  distribution	  and	  Band-­‐Gap.	  	  	  






TIO2	  200°C	   111.2	   2-­‐30	   3.4	  
TIO2	  400°C	   53.6	   2-­‐30	   3.32	  
TIO2	  600°C	   10	   0.5-­‐50	   3.1	  
TIO2	  650°C	   1.9	   0.5-­‐70	   3.04	  
TIO2	  700°C	   1.2	   0.5-­‐70	   3.03	  
TIO2	  750°C	   1.4	   1-­‐100	   3.00	  
TIO2	  COMMERCIAL	  
204757	  
2	   0.5-­‐1	   3.09	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Upon	   production	   of	   the	   different	   calcined	   powders,	   their	   ROS	   scavenging	  
capacity	   was	   chemically	   analysed	   using	   artificial	   ROS	   (SIN-­‐1	   and	   DPPH	   methods)	  
Previous	   results	   showed	   that	   the	   600°C	   calcined	   powder	   presented	   the	   best	  
percentage	   of	   ROS	   scavenging.	   This	   powder	   is	   constituted	   by	   a	  mixture	   of	   different	  
phases	   (anatase	   phase	   of	   77%	   and	   rutile	   phase	   23%).	   Furthermore,	   we	   performed	  
mixtures	  of	  different	  ratios	  of	   the	  200°C	  calcined	  powder	  only	  at	  anatase	  phase,	  and	  
700°C,	  mainly	  at	   rutile	  phase	   (97	  %).	   The	  aim	  was	   to	  evaluate	   if	   combining	  powders	  
with	   different	   phases,	   we	   could	   obtain	   a	   biomaterial	   exhibiting	   a	   higher	   ROS	  
scavenging	  capacity.	  	  
Our	  main	  goal	   it	   to	  verify	   if	  TiO2	   is	  able	   to	  degrade	   the	  ROS	  produced	  by	   the	  
cells	   from	   the	   BRB	  mainly	   RPE	   and	   endothelial	   cells.	   Nevertheless,	   it	   is	   essential	   to	  
firstly	  establish	  a	  cellular	  model.	   In	   this	  way	   it	  was	  used	  macrophages	  since	   it	   is	  well	  
known	   that	   they	   produce	   high	   levels	   of	   ROS	   upon	   activation	   (65,66).	   Additionally,	  
along	  with	  inflammation	  associated	  with	  AMD,	  the	  macrophages	  start	  to	  be	  recruited	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2.1 Materials  
The	  materials	  used	  for	  each	  assay	  are	  described	  in	  Appendix	  A	  tables.	  This	  work	  
is	   an	   integral	   part	   of	   the	   BIOAMD	   –	   biomaterials	   for	  modulation	   of	   inflammation	   in	  
Age-­‐related	  macular	  Degeneration	  project	  that	  is	  in	  collaboration	  with	  the	  Instituto	  de	  
Cerámica	  y	  Vidrio	  del	  CSIC	  from	  Spain	  and	  the	  University	  of	  Pisa	  in	  Italy.	  In	  this	  regard,	  
the	  different	  used	  titanium	  dioxide	  powders	  (TiO2)	  were	  produced	  and	  provided	  by	  the	  
CSIC	  and	  the	  used	  bioreactor	  systems	  were	  produced	  and	  provided	  by	  the	  University	  of	  
Pisa.	  	  	  
	  
2.2 Methodology  
2.2.1 Chemical Assays  
Scavenging of 2,2-diphenyl-1-picrylhydrazyl (DPPH) in the presence of 
titanium dioxide powders 
	  
To	  assess	  the	  ROS	  scavenging	  capacity	  of	  the	  titanium	  dioxide	  powders	  a	  DPPH	  
assay	  was	  performed	  using	  the	  protocol	  described	  below.	  	  
DPPH	   is	   a	   stable	   free	   radical	   in	   which	   the	   capacity	   to	   be	   scavenged	   can	   be	  
expressed	  as	  a	  measure	  of	  antioxidant	  activity	   (67).	  The	  purple	  chromogen	   radical	   is	  
reduced,	   either	   by	   direct	   hydrogen	   transfer	   or	   by	   indirect	   electron	   and	   proton	  
donation	  to	  the	  corresponding	  pale	  yellow	  hydrazine	  (figure	  2.1).	  Consequently,	  there	  




Figure	  2.1	  –	  DPPH	  reduction	  chemical	  reaction	  accompanied	  by	  its	  colour	  modification.	  	  	  	  	  	  
	  
Firstly	  it	  was	  prepared	  three	  replicas	  of	  0,1	  mM	  DPPH	  solution	  in	  the	  absence	  of	  
calcined	   TiO2	   powders.	   Since	   there	   was	   not	   ROS	   scavenging,	   this	   represents	   the	  
maximum	  DPPH	  value	  in	  solution.	  In	  order	  to	  analyse	  the	  absorbance	  of	  the	  solution,	  it	  
was	   added	   100	   µl	   from	   the	   sample	   to	   400	   µl	   of	   isopropanol.	   Subsequently,	   the	  
absorbance	  was	  measured	   in	   a	   spectrophetometer	  UV-­‐VIS	   at	   517	   nm.	  On	   the	   other	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hand,	   it	  was	  prepared,	  as	  negative	  control,	  three	  replicas	  with	  50	  mg	  of	  each	  type	  of	  
calcined	  TiO2	  powders	  (table	  2.1)	  diluted	  on	  500	  µl	  of	  isopropanol	  and	  in	  the	  absence	  
of	  0,1	  mM	  DPPH	  solution.	   In	  order	   to	  analyse	   the	   scavenging	  capacity	  of	  TiO2,	   three	  
replicas	  with	  50	  mg	  of	  each	  type	  of	  calcined	  TiO2	  powder	  was	  diluted	  on	  0,1	  mM	  DPPH	  
solution.	  	  	  	  	  	  	  	  	  
	  






The	   suspensions	   were	   incubated,	   in	   the	   thermomixer	   and	   in	   the	   dark,	   for	   a	  
period	  of	  30	  minutes	  with	  agitation	   (1200	  rpm)	  at	  21°C.	  Afterwards,	   the	  suspensions	  
were	   centrifuged	   (eppendorf	   5417R)	   at	   13000	   rpm	   during	   3	  min	   and	   100	   µl	   of	   the	  
supernatant	   were	   collected	   and	   added	   to	   400	   µl	   of	   isopropanol.	   The	   absorbance,	  
proportional	   to	   the	  ROS	   levels,	  was	  measured	   in	  a	  spectrophotometer	  UV-­‐VIS	  at	  517	  
























TiO2	  	  	  25	  %	  200°C	  /	  75	  %	  700°C	  
TiO2	  	  	  50	  %	  200°C	  /	  50	  %	  700°C	  
TiO2	  	  	  75	  %	  200°C	  /	  25	  %	  700°C	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Scavenging of 3-Morpholinosyndnomine (SIN-1) in the presence of titanium 
dioxide powders 
	  
SIN-­‐1	  (figure	  2.3)	  has	  been	  used	  to	  generate	  nitric	  oxide	  (•NO)	  and	  superoxide	  
(O2•
-­‐).	  The	  reaction	  between	   •NO	  and	  O2•
-­‐	   give	   rise	   to	  peroxynitrite	   (ONOO-­‐),	  a	  potent	  





Figure	  2.3	  –	  Chemical	  formula	  of	  SIN-­‐1.	  	  
	  
SIN-­‐1	  was	  firstly	  diluted	  in	  PBS	  1X	  to	  a	  concentration	  of	  10	  mM	  and,	  afterwards,	  
the	  final	  concentration	  of	  25	  µM	  is	  achieved	  by	  diluting	  the	  previous	  solution	  in	  aCSF	  
medium.	  The	  artificial	  cerebrospinal	   fluid	  (aCSF)	  medium	  is	  constituted	  by	  5	  mM	  KCl,	  
120	  mM	  NaCl,	  1,4	  mM	  CaCl2,	  1,2	  mM	  MgCl2,	  5	  mM	  D-­‐Glucose	  and	  PBS	  0,2X.	  	  	  	  
The	   procedure	   used	   to	   analyse	   the	   scavenging	   capacity	   of	   SIN-­‐1	   by	   different	  
calcined	  TiO2	  powders	  was	  identically	  to	  the	  one	  used	  for	  the	  DPPH	  free	  radical.	  Firstly,	  
it	  was	  prepared	  three	  replicas,	  representing	  the	  maximum,	  of	  25	  µM	  SIN-­‐1	  solution	  in	  
the	   absence	  of	   calcined	  TiO2	  powders.	   The	   three	   replicas	  of	   the	   controls	   (minimum)	  
was	  prepared	  by	  adding	  50	  mg	  of	  each	  calcined	  TiO2	  to	  500	  µl	  of	  aCSF	  medium	  in	  the	  
absence	   of	   25	   µM	   SIN-­‐1	   solution.	   To	   analyse	   the	   scavenging	   capacity	   of	   TiO2,	   three	  
replicas	  three	  replicas	  with	  50	  mg	  of	  each	  type	  of	  calcined	  TiO2	  powder	  was	  diluted	  on	  
25	  µM	  SIN-­‐1	  solution.	  	  	  	  
The	  suspensions	  were	  incubated,	  within	  the	  thermomixer	  and	  in	  the	  dark,	  for	  a	  
period	  of	  30	  minutes	  with	  agitation	   (1200	  rpm)	  at	  21°C.	  Afterwards,	   the	  suspensions	  
were	   centrifuged	   (eppendorf	   5417R)	   at	   13000	   rpm	   during	   3	  min	   and	   150	   µl	   of	   the	  
supernatant	  were	   collected	   and	   50µl	   of	   250	  µM	  2',	   7’-­‐dichlorofluorescein	   (DCF)	  was	  
added.	  When	  DCF	  were	  in	  the	  presence	  of	  ONOO-­‐	  forms	  a	  fluorescent	  complex	  and	  the	  
fluorescence	  is	  measured.	  Briefly,	  DCF	  is	  prepared	  from	  its	  precursor	  DCFDAH2,	  which	  
was	   diluted	   in	   PBS	   1X	   to	   a	   final	   concentration	   of	   5	   mM.	   In	   order	   to	   neutralize	   the	  
solution	  and	  therefore	  obtain	  DCF,	  1600	  µL	  of	  0,1	  M	  KOH	  were	  added	  to	  400	  µL	  of	  the	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previous	   solution	   and	   the	   resulting	   mixture	   was	   further	   incubated	   at	   room	  
temperature	   and	   in	   the	  dark	   for	   an	   additional	   period	  of	   30	  min.	  After	   the	  period	  of	  
incubation,	   the	   solution	  was	  diluted	  with	  6	  ml	  of	  PBS	  10X	  and	   the	  DCF	   reaches	   to	  a	  
final	   concentration	   of	   250	   µM.	   The	   fluorescence	   was	   analyzed	   in	   a	   plate	   reader	  
(Synergy	   HT	   BioTek)	   using	   a	   wavelength	   of	   488	   nm	   of	   excitation	   and	   517	   nm	   of	  
emission	  using	  the	  Gen5	  software.	  	  
	  
2.2.2 Cell culture 	  
Human monocytic leukemia cell line culture 
	   In	  the	  present	  study,	  it	  was	  used	  the	  human	  monocytic	  leukemia	  cell	  line	  (THP-­‐
1),	  purchased	  from	  ATCC.	  THP-­‐1	  cells	  are	  single,	  round	  cells	  cultured	  in	  suspension	  that	  
resemble	   primary	  monocytes	   and	  macrophages	   in	  morphology	   and	   have	   the	   typical	  
monocytic	  markers	   (70).	   THP-­‐1	  were	   cultured	   in	   RPMI	   1640	  medium,	   supplemented	  
with	  GlutaMax™	  a	  dipeptide	   (L-­‐alanyl-­‐L-­‐glutamin)	   substitute	   for	   L-­‐Glutamin,	   know	   to	  
improve	   growth	   efficiency	   and	   performance	   of	  mammalian	   cell	   culture	   system.	   The	  
cells	  were	  maintained	  at	  37°C	  and	  5%	  of	  CO2.	  
	  
THP-1 differentiation and activation   
	   The	   differentiation	   of	   THP-­‐1	   cell	   line	   into	   macrophages	   can	   be	   induced	   by	  
treatments	   with	   phorbol	   esters	   like	   phorbol	   12-­‐myristate	   13-­‐acetate	   (PMA).	   When	  
exposed	  to	  PMA,	  THP-­‐1	  cells	  adhere	  to	  the	  cell	  culture	  plates,	  acquire	  a	  macrophage	  
phenotype	  with	  marked	  morphological	  changes	  –	  flat	  and	  amoeboid	  in	  shape	  with	  well	  
developed	   Golgi	   apparatuses,	   rough	   endoplasmatic	   reticula,	   large	   number	   of	   free	  
ribosomes	   in	  the	  cytoplasm	  (71).	  A	  stock	  solution	  of	  1	  mg/ml	  of	  PMA	  in	  ethanol	  was	  
prepared	   and	  diluted	   in	   the	  medium	   to	   a	   final	   concentration	  of	   0,5	  µg/ml.	   The	   cells	  
were	  completely	  differentiated	  after	  an	  incubation	  period	  of	  48h.	  	  
To	  activate	  the	  THP-­‐1	  macrophages	  bacterial	  lipopolysaccharide	  (LPS),	  a	  major	  
component	   of	   gram-­‐negative	   bacteria	   and	   one	   of	   the	   most	   microbial	   initiators	   of	  
inflammation,	  was	  used.	  Cells	  were	  seeded	  in	  contact	  with	  50	  ng/ml	  LPS	  for	  a	  period	  of	  
48	  h	  prior	  use.	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Culture of macrophages in a transwell system in the presence of TiO2   
	   Macrophages	   in	   their	   basal	   activity	   secrete	   ROS	   and	   when	   activated	   the	  
secreted	   ROS	   levels	   significantly	   increase.	   Therefore,	   in	   order	   to	   evaluate	   the	  
macrophage	   produced	   ROS	   scavenging	   capacity	   by	   different	   TiO2	   powders	   –	  
commercial	  and	  calcined	  at	  different	   temperatures	   (200°C	  and	  600°C),	  a	  non-­‐contact	  
culture	  transwell	  system	  was	  established	  (Figure	  2.4).	  TiO2	  powders	  were	  weighed	  (10	  
mg)	   and	   successively	   suspended	   in	   complete	   culture	   media	   in	   order	   to	   achieve	  
different	   concentrations	   of	   powder	   in	   suspension	   (5	   mg/ml,	   1	   mg/ml).	   These	  
suspensions	  were	  added	  to	  the	  bottom	  of	  a	  12-­‐well	  plate.	  The	  transwells	  (pore	  size	  of	  
0,4	  µm)	  were	  added	  to	  each	  well	  and	  non-­‐activated	  or	  activated	  macrophages	  (0,500	  x	  
106	   cells/well)	   were	   seeded	   on	   top	   of	   the	   transwell	   system	   using	   complete	   culture	  
media.	  
The	   viability	   of	   the	   cells	   were	   analysed	   after	   a	   period	   of	   24hrs	   or	   48hrs	   of	  
incubation.	   On	   the	   other	   hand,	   the	   presence	   of	   ROS	   in	   the	   supernatant	   and	   the	  
intrecellular	   ROS	   were	   analysed	   48hrs	   after	   culture.	   In	   both	   cases	   were	   performed	  






Figure	   2.4–	   Schematic	   representation	   of	   the	   transwell	  model.	   TiO2	   is	   placed	   on	   the	   lower	   compartment	   and	   the	  
macrophages	  were	  seeded	  on	  the	  top	  of	  the	  transwell	  membrane.	  	  	  	  	  	  	  
	  
Cell metabolic activity  
Cell	   viability	  was	   assessed	   through	   the	   evaluation	   of	   the	  metabolic	   activity	   of	  
cells	   based	   on	   the	   resazurin	   assay.	   Briefly,	   the	   resazurin	   assay	   represents	   a	   simple,	  
rapid	   and	   sensitive	   measurement	   of	   the	   assessment	   of	   cell	   viability.	   The	   non-­‐
fluorescent	   dye	   resazurin	   can	   be	   converted	   in	   the	   mitochondria	   in	   the	   strongly	  
fluorescent	   dye	   resorufin	   under	   the	   presence	   of	   living	   cells,	  which	   are	  metabolically	  
active	   (figure	   2.5).	   A	   resazurin	   solution	   was	   added	   on	   both	   compartments	   of	   the	  
transwell	   to	   a	   final	   concentration	   of	   10	  %	   (v/v)	   After	   4	   hrs	   of	   incubation,	   200	   µL	   of	  
medium	  were	  removed	  from	  the	  upper	  part	  of	  the	  transwell	  and	  added	  into	  a	  96	  well	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plate	  and	  the	  fluorescence	  measured	  in	  a	  plate	  reader	  (Synergy	  HT	  BioTek)	  using	  560	  





Figure	  2.5	  –	  Resazurin	  chemical	  reaction.	  	  
	  
Evaluation of the presence of ROS in the supernatant 
	  After	   the	   set	   incubation	   period,	   150	  µl	   of	   supernatant	   from	   the	   bottom	  and	  
upper	   compartment	   of	   the	   transwell	   system	   was	   collected	   and	   plated	   in	   a	   96-­‐well	  
plate	   and	   50	   µl	   of	   250	   µM	   DCF	   was	   added.	   The	   fluorescence,	   proportional	   to	   the	  
amount	   of	   ROS,	   was	   measured	   in	   a	   plate	   reader	   (Synergy	   HT	   BioTek)	   using	   a	  
wavelength	  of	  488	  nm	  of	  excitation	  and	  517	  nm	  of	  emission	  and	  with	  Gen5	  software.	  








Figure	  2.6	  –	  Schematic	  representation	  of	  the	  evaluation	  of	  ROS	  in	  the	  supernatant	  from	  basal	  side.	  	  	   
	  
Evaluation of the presence of ROS inside the cells  
After	   the	  set	   incubation	  period,	  10	  µl	   from	  a	  solution	  of	  5	  mM	  DCFDAH2	  was	  
added	  into	  the	  upper	  part	  of	  the	  traswell	  systems.	  DCFDAH2	  is	  an	  indicator	  for	  ROS	  in	  
cells.	  Upon	  cleavage	  of	  the	  acetate	  groups	  by	  intracellular	  esterases	  and	  oxidation,	  the	  
compound	  is	  converted	  in	  the	  fluorescent	  compound	  DCF.	  	  
To	  ensure	  the	   incorporation	  of	  DCFDAH2	  by	  the	  cells,	   they	  were	   incubated	  for	  
1,5	   hrs	   prior	   the	   evaluation	   with	   DCFDAH2	   in	   a	   final	   concentration	   of	   25	   µM.	  
Afterwards	  the	  media	  was	  removed,	  cells	  were	  trypsinized	  (350	  µl)	  for	  a	  period	  of	  5	  to	  
10	  minutes	  and	  placed	  onto	  a	  new	  12-­‐well	  plate,	  and	  1	  ml	  of	  complete	  media	  added	  in	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order	   to	   inactivate	   the	   trypsin.	   Cells	   were,	   subsequently,	   centrifuged	   (eppendorf	  
5417R)	   at	   13000	   rpm	   during	   3	   minutes	   and	   re-­‐suspended	   in	   1	   ml	   of	   PBS	   1X.	   The	  
presence	  of	   intracellular	  ROS	  was	  then	  analysed	  by	   flow	  cytometry	   in	  a	  FACS	  Calibur	  
flow	   cytometer	   (BD	   Biosciences)	   with	   the	   Cell	   Quest	   software.	   The	   obtained	   results	  
were	   analyzed	   using	   the	   FlowJo	   software.	   Figure	   2.7	   schematically	   represents	   the	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2.2.3 Bioreactor 
Figure	   2.8	   –	   Bioreactor.	   System	   A	   –	   Schematically	   representation	   of	   the	   closed-­‐loop	   bioreactor	   system.	   B	   –	  
bioreactor	  system.	  C	  –	  new	  bioreactor	  system.	  	  	  	  
	  
The	  bioreactor,	  based	  on	  poly	  (methylsiloxane)	  (PDMS),	  is	  mainly	  composed	  of	  
an	   upper,	   bottom	   chamber	   and	   between	   them	   a	   holder	   system	   can	   be	   found	   that	  
supports	  a	  polycarbonate	  membrane.	  During	  work	  we	   faced	   some	  difficulties	  mainly	  
concerning	  cell	  culture.	  In	  this	  regard	  the	  components	  of	  the	  bioreactor	  suffered	  some	  
modifications	  and	  a	  new	  system	  arise.	  The	  system	  is	  connected	  to	  a	  peristaltic	  pump	  
(ISMATEC	  ISM931)	  that,	  therefore,	  induces	  a	  flow	  rate.	  This	  flow	  rate	  is	  defined	  by	  the	  
setting	  established	  in	  the	  peristaltic	  pump	  and	  by	  the	  diameter	  of	  the	  connecting	  tube	  
used.	  An	  inlet	  tube	  goes	  out	  from	  the	  mixing	  chamber,	  which	  acts	  as	  a	  liquid	  container,	  
and	   passes	   through	   the	   peristaltic	   pump	   before	   the	   connection	   to	   the	   inlet	   of	   the	  
chamber.	   Once	   the	   bioreactor	   chamber	   is	   completely	   filled	   in,	   the	   medium	   is	  
conducted	   again	   to	   the	  mixing	   chamber	   by	   an	   outlet	   tube.	   Hence,	   each	   chamber	   is	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The	  upper	  chamber	   (Figure	  2.9)	  has	  a	  volume	  of	  1	  ml	  and	  an	   inlet	  and	  outlet	  
tube	  with	  a	  respectively	  inner	  diameter	  of	  1	  mm	  and	  2	  mm.	  The	  presence	  of	  an	  inlet	  
and	  outlet	  tube	  among	  with	  the	  cylindrical	  shape	  of	  the	  chamber	  enables	  the	  presence	  
of	   a	   laminar	   flow.	   To	   assure	   an	   efficient	   bubble	   removal	   prior	   the	   start	   of	   the	  
experiment	  the	  inlet	  and	  outlet	  tubes	  have	  different	  inner	  diameters	  and	  the	  chamber	  






Figure	  2.9	  –	  Photograph	  of	  the	  bioreactor	  upper	  chamber.	  
	  
Bottom chamber 
The	   bottom	   chamber,	   similar	   to	   the	   upper	   chamber,	   has	   an	   inlet	   and	   outlet	  
tube	  with	  1	  mm	  and	  2	  mm	  of	  inner	  diameter,	  respectively,	  and	  also	  a	  cylindrical	  shape.	  	  
The	  bottom	  chamber	  has	  a	  flat	  silicone	  base	  and	  the	  coverslips	  can	  easily	  stick	  
to	   the	   base	   hindering	   the	   coverslip	   removal	   without	   cause	   any	   damage	   to	   the	   cells	  
(figure	   2.10A).	  Moreover,	  with	   a	   partially	   opaque	   surface,	   it	   is	   almost	   impossible	   to	  
observe	  the	  cells	  in	  the	  microscope	  within	  the	  bioreactor	  system.	  	  
As	  mentioned	  before,	  during	  work	  a	  new	  bioreactor	  system	  was	  developed	  and	  
the	   bottom	   chamber	   was	   re-­‐designed	   in	   order	   to	   eliminate	   some	   of	   its	   drawbacks.	  
Instead	  of	  having	  just	  one	  piece,	  the	  chamber	  is	  subdivided	  into	  three	  parts:	  a	  support	  
for	   the	   coverslip	   (Figure	   2.10B),	   a	   coverslip	   (Figure	   2.10C)	   and	   a	   ring	   containing	   the	  
inlet	  and	  outlet	  tube	  (Figure	  2.10D).	  Therefore,	  with	  these	  alterations	  became	  easier	  to	  
handle	  the	  coverslip	  and	  is	  possible	  to	  observe	  the	  cells	   in	  the	  microscope	  within	  the	  
system.	   As	   a	   consequence	   of	   these	   modifications,	   the	   bottom	   chamber	   reduces	   its	  
volume	  from	  1,5	  ml	  to	  1	  ml.	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Figure	   2.10	   –	   Bottom	   Chamber.	   A	   –Bottom	   chamber	   from	   the	   first	   system.	   B	   –	   Support	   for	   the	   coverslip.	   C	   –	  
Coverslips.	  D	  –	  ring	  containing	  the	  inlet	  and	  outlet	  tube.	  E	  –	  Connection	  of	  the	  three	  parts	  of	  the	  bottom	  chamber,	  
representing	  the	  bottom	  chamber	  from	  the	  second	  system.	  	  	  	  	  	  
	  
Holder system  
The	  holder	  system	  is	  composed	  of	  two	  cylindrical	  parts,	  upper	  and	  bottom	  that	  
connects,	   due	   to	   the	   male-­‐female	   joints,	   to	   the	   upper	   and	   bottom	   chambers,	  
respectively.	  The	  membrane	  is	  inserted	  between	  the	  two	  parts	  and	  once	  assembled,	  it	  
can	  be	  handled	  without	  touching	  or	  damaging	  the	  membrane.	  The	  male	  joint	  is	  part	  of	  
the	  upper	  holder	  and	  it	   is	  used	  to	  press	  the	  membrane	  peripheral	  region,	   in	  order	  to	  
avoid	  any	  misalignment.	  The	  central	  region	  of	  the	  membrane	  must	  form	  a	  flat,	  smooth	  
plane	  in	  order	  to	  allow	  cell	  seeding.	  	  
In	  the	  first	  bioreactor	  system	  these	  two	  cylindrical	  parts	  were	  made	  by	  PDMS	  
(Figure	  2.11A).	  In	  the	  new	  system,	  the	  holder	  system	  also	  underwent	  some	  alterations.	  
In	  order	  to	  further	  reduce	  the	  membrane	  manipulation	  the	  material	  was	  changed	  to	  a	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Figure	  2.11	  –	  Holder	  System.	  A	  –holder	  system	  from	  the	  first	  system.	  B1	  –	  Holder	  system	  of	  the	  second	  system.	  B2	  –	  
The	  two	  components	  of	  the	  holder	  system	  from	  the	  second	  system. 
 
Clamp system   
The	   clamp	   system	   assured	   the	   watertightness,	   since	   it	   imposes	   a	   suitable	  
pressure	  to	  avoid	  any	  leakage.	  	  	  
In	   the	   first	   bioreactor	   system	   the	   clamp	   system	   (figure	   2.12A	   and	   B)	   was	  
constituted	  of	  two	  plastic	  discs	  that	  impress	  pressure	  and	  ensure	  the	  water	  tightness.	  
In	   order	   to	   close	   the	   system,	   there	   is	   an	   O-­‐ring	   that	   connects	   the	   two	   discs.	   A	  
cylindrical	   slot	   is	   needed	   to	   insert	   the	   bottom	   chamber	   and	   its	   thickness	   has	   to	   be	  
taken	  into	  account	  in	  order	  to	  avoid	  the	  compression	  of	  the	  connecting	  tubes.	  	  
Due	  to	  the	  aforementioned	  modifications	  in	  the	  bioreactor	  system	  and	  aiming	  
at	  the	  visualization	  of	  the	  lower	  chamber	  in	  the	  microscope,	  the	  clamp	  system	  of	  the	  
new	   bioreactor	   system	   experienced	   some	   modifications.	   (Figure	   2.12	   C	   and	   D).	   To	  
close	  the	  system	  there	  is	  a	  S-­‐clamp	  system	  that	  fits	  in	  the	  slops	  of	  the	  bars	  present	  in	  
the	  support.	  This	  support	  needs	  also	  a	  slot	  to	  insert	  the	  bottom	  chamber	  and	  also	  one	  
to	  fit	  the	  inlet	  and	  outlet	  tube	  due	  to	  the	  reduction	  of	  bioreactor	  size.	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Figure	   2.12	   –	   Clamp	   System.	   A,	   B	   –	   Clamp	   System	   from	   the	   first	   system.	   C,	   D	   –	   Clamp	   System	   from	   the	   second	  
system.	  	  	  	  	  	  
	  
Evaluation of the permeability of the system with methylene blue   
The	  permeability	  of	  the	  system	  was	  evaluated	  by	  using	  methylene	  blue.	  Firstly	  
it	  was	  setup	  a	  simpler	  system,	  under	  static	  conditions,	  where	  there	  is	  no	  flow	  and	  the	  
passage	  of	  the	  compound	  from	  the	  upper	  to	  the	  bottom	  chamber	  only	  occurs	  due	  to	  
the	  gravity	  force.	  Subsequently,	  dynamic	  conditions	  were	  tested	  at	  a	  flow	  rate	  of	  150	  
µl/min	  and	  300	  µl/min	  for	  the	  bottom	  and	  upper	  chamber,	  respectively	  that	  gave	  rise	  
to	   a	   laminar	   flow	   within	   the	   chambers.	   	   The	   upper	   and	   bottom	   chamber	   were,	  
respectively,	  filled	  in	  with	  0,25	  mg/ml	  methylene	  blue	  and	  distilled	  water.	  Under	  static	  
conditions	   the	   solutions	  were	  placed	  within	   the	   chamber	  with	   the	  help	  of	   a	   syringe.	  
The	  samples	  were	  collected	  with	  a	  needle	  and	  syringe,	  which	  was	  inserted	  within	  the	  
outlet	  tube	  of	  the	  chamber.	  Under	  this	  strategy	  of	  sample	  removal	   it	  was	  possible	  to	  
extract	   the	   sample	   from	  the	  central	  part	  of	   the	  bioreactor	  chamber	  otherwise	   it	  will	  
not	  be	  possible	  to	  analyse	  the	  diffusion	  of	  methylene	  blue.	  Under	  dynamic	  conditions,	  
the	   compounds	   were	   placed	   within	   the	   mixing	   chamber	   connected	   to	   the	   upper	  
chamber	  and	  with	  the	  defined	  flow	  rate	  in	  the	  peristaltic	  pump,	  the	  fluid	  moves	  from	  
the	  mixing	  chamber	  to	  the	  bioreactor	  chamber.	  Here,	  the	  samples	  were	  collected	  with	  
a	  connector	  placed	  immediately	  after	  the	  outlet	  tube	  of	  each	  bioreactor	  chamber.	  The	  
reading	  samples	  were	  prepared	  with	  25	  µl	  collected	  from	  the	  chamber	  and	  475	  µl	  of	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distilled	  water.	  Afterwards,	  the	  absorbance	  was	  measure	  in	  a	  spectrophotometer	  UV-­‐
VIS	  at	  610	  nm	  corresponding	  to	  the	  maximum	  absorbance	  of	  the	  methylene	  blue.	  	  	  
	  
Evaluation of the ROS passage through the polycarbonate membrane – 
DPPH and SIN-1     
	  
In	  order	  to	  evaluate	  the	  ROS	  diffusion	  capacity	  from	  the	  upper	  to	  the	  bottom	  
chamber	   it	  was	   performed	   assays	  with	   DPPH	   and	   SIN-­‐1	   under	   static	   and	  with	   SIN-­‐1	  
under	  dynamic	  conditions.	  It	  was	  tested	  two	  different	  conjugation	  of	  flow	  rate,	  firstly	  a	  
flow	  rate	  equal	   to	   the	  previous	  one	   (150	  µl/min	  and	  300	  µl/min	   for	   the	  bottom	  and	  
upper	   chamber,	   respectively)	   and	   then	   the	   flow	   rate	  was	   increase	   to	  200	  µl/min	   for	  
the	  bottom	  chamber	  and	  400	  µl/min	  for	  the	  upper	  chamber.	  	  
Regarding	   the	   DPPH	   assay,	   the	   upper	   chamber	   was	   filled	   in	   with	   a	   0,1	   mM	  
DPPH	  solution	  and	  the	  bottom	  chamber	  with	   isopropanol.	  On	  the	  other	  hand,	   in	   the	  
SIN-­‐1	   assay,	   the	   upper	   chamber	   was	   filled	   in	   with	   a	   25	   µM	   SIN-­‐1	   solution	   and	   the	  
bottom	  chamber	  with	  aCSF.	  The	  solutions	  were	  prepared	  and	  the	  samples	  measured	  
as	  mentioned	  above.	  	  	  
	  
Culture of macrophages in the bioreactor system 	  
The	   non-­‐activated	   or	   activated	  macrophages	   were	   seeded,	   with	   a	   density	   of	  
0,500	  x	  106	  cells/membrane,	  on	  the	  polycarbonate	  membrane	  inside	  the	  holder	  and	  on	  
a	  6	  well	  plate.	  After	  4	  hrs	  the	  macrophages	  adhere	  to	  the	  membrane	  and	  the	  holder	  
was	   sandwiched	   between	   the	   two	   chambers,	   which	   were	   filled	   up	   with	   complete	  
medium.	  The	  apical	  circuit	  was	  filled	  with	  10	  ml	  of	  complete	  medium	  and	  in	  the	  case	  of	  
activated	  macrophages,	  we	   added	   LPS	   in	   order	   to	   keep	   the	   activation	   stimulus.	   The	  
basal	   circuit	  was	   filled	  with	   10	  ml	   of	   complete	  medium.	   Afterwards,	   the	   circuit	  was	  
closed	   and	   a	   flow	   rate	   of	   150	   µl/min	   and	   300	   µl/min	   for	   the	   bottom	   and	   upper	  
chamber,	  respectively,	  was	  applied	  for	  48hrs.	  Additional	  to	  the	  dynamic	  system,	  it	  was	  
established	  an	  identical	  system	  under	  static	  condition	  as	  a	  control.	  	  
The	  macrophages	  metabolic	   activity	   and	   the	   ROS	   passage	   from	   the	   upper	   to	  
the	  bottom	  chamber	  were	  analysed	  after	  48hrs	  of	  culture.	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Cell metabolic activity and evaluation the presence of ROS in the 
supernatant  
 
After	  the	  incubation	  period	  and	  similarly	  with	  the	  chemical	  assays	  150	  µl	  from	  
the	   supernatant	   was	   collected.	   The	   presence	   of	   ROS	   was	   analysed	   as	   mentioned	  
above.	  	  	  
In	   order	   to	   evaluate	   the	   cell	   metabolic	   activity,	   the	   chambers	   were	  
disassembled	  in	  a	  first	  place	  and	  the	  holder	  system	  was	  transferred	  to	  a	  12	  well	  plate	  
and	  it	  was	  added	  completed	  medium	  supplemented	  with	  10	  %	  (v/v)	  of	  resazurin.	  After	  
4	  hrs	  of	  incubation,	  it	  was	  removed	  200	  µl	  from	  the	  supernatant	  and	  the	  sample	  was	  
measured	  as	  mentioned	  above.	  	  
	  
2.2.4 Statistical analysis  
All	  statistical	  analyses	  were	  performed	  with	  GraphPad	  Prism®	  software	  (Prism	  6	  
for	  Mac	  OS	  X).	  Data	  were	  presented	  as	  mean	  ±	  standard	  deviation	  (SD).	   	  Student’s	  t-­‐
test	  was	  used	  to	  compare	  two	  sets	  of	  measurements.	  To	  determin	  how	  a	  response	  is	  
affected	   by	   two	   factors	   was	   used	   the	   two-­‐way	   ANOVA	   complemented	  with	   Tukey’s	  
multiple	   comparisons	   test.	  Differences	   at	  P<	  0,05	  were	   considered	   to	  be	   statistically	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3.1 Chemical Assays  
3.1.1 Scavenging of 2,2-diphenyl-1-picrylhydrazyl (DPPH) in the presence of 
titanium dioxide  (TiO2)    
The	   ROS	   scavenging	   capacity	   of	   the	   different	   TiO2	   powders	   mixtures	   are	  
represented	  in	  Figure	  3.1.	  The	  graphic	  also	  presents	  the	  ROS	  scavenging	  capacity	  of	  the	  












Figure	  3.1	  –	  Graphic	  representing	  the	  percentage	  of	  scavenging	  of	  DPPH	  by	  the	  different	  TiO2	  powders.	  Data	  
represents	  the	  mean	  ±	  standard	  deviation	  (S.D),	  (n=3).	  	  	  	  	  
The	  scavenging	  capacity	  of	  200°C	  and	  700°C	  TiO2	  powders	  were,	   respectively,	  
60%	  and	  23%,	  whereas	  the	  scavenging	  capacity	  of	  the	  mixtures	  with	  different	  ratios	  of	  
both	  TiO2	  powders	   varies	   from	  37%	   to	  51%.	   Therefore,	   these	   results	   reveal	   that	   the	  
combination	   of	   different	   ratios	   of	   the	   200°C	   and	   700°C	   calcined	   powders	   did	   not	  
improve	   the	   scavenging	   capacity	   of	   DPPH.	   Also,	   these	   results	   show	   that	   the	   200°C	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3.1.2 Scavenging of 3-Morpholinosyndnomine (SIN-1) in the presence of 
titanium dioxide  (TiO2)    
A	   similar	   assay	  was	  performed	  with	   SIN-­‐1.	   The	   assay	  with	   SIN-­‐1	   represents	   a	  
better	  correlation	  with	  the	  physiological	  conditions.	  This	  correlation	  is	  achieved	  since	  
DPPH	  is	  diluted	  in	  isopropanol	  (non	  physiological	  solution)	  and	  SIN-­‐1	  is	  diluted	  in	  aCSF	  












Figure	   3.2	   –	   Graphic	   representing	   the	   percentage	   of	   scavenging	   of	   SIN-­‐1	   by	   the	   different	   TiO2	   powders.	   Data	  
represents	  the	  mean	  ±	  S.D,	  (n=2).	  	  	  	  	  
As	  showed	  in	  the	  previous	  results	  with	  DPPH,	  the	  results	  of	  SIN-­‐1	  scavenging	  by	  
the	  mixture	  of	  different	  powders	  also	  include	  previous	  results	  of	  the	  commercial	  and	  
600°C	   powder,	   as	   controls.	   Even	   with	   SIN-­‐1,	   there	   is	   a	   tendency	   to	   obtain	   better	  
scavenging	   of	   ROS	   by	   the	   powders	   individually.	   Indeed,	   the	   scavenging	   capacity	   of	  
200°C	   and	   700°C	   powders	   was	   52%	   and	   44%,	   respectively	   and	   the	   scavenging	  
percentage	  of	  the	  different	  mixtures	  were	  in	  between,	  varying	  from	  39%	  to	  47%.	  	  	  
All	  together,	  these	  results	  pointed	  out	  that	  comparatively	  to	  the	  mixtures,	  the	  
individual	  powders	  have	  a	  higher	  scavenging	  capacity	  and	  the	  200°C	  and	  600°C	  appear	  
to	  be	  the	  most	  promising	  TiO2	  powders.	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3.2 Cell Culture  
Once	  chemically	  analysed	  the	  TiO2	  scavenging	  capacity	  and	  concluded	  that	  the	  
200°C	  and	  600°C	  powders	  seems	  to	  have	  the	  most	  promising	  scavenging	  capacity,	  the	  
following	   step	   is	   to	   analyse	   the	   TiO2	   scavenging	   capacity	   of	   the	   ROS	   produced	   by	  
macrophages.	   The	   used	   TiO2	   powders	   are	   the	   200°C	   and	   600°C	   along	   with	   the	  
commercial	   204757	   as	   a	   control.	   Therefore,	   the	   assays	   with	   macrophages	   were	  
performed	  with	  these	  powders.	  
	  
3.2.1 Human monocytic leukemia cell line expansion   
Macrophages	  can	  be	  derived	  from	  the	  THP-­‐1	  cell	   line,	  which	  are	  single,	  round	  
suspension	  cells	   (Figure	  3.3).	  This	  cell	   line	  has	  some	  advantages	  over	  human	  primary	  
monocytes-­‐macrophages.	   Their	   homogeneous	   genetic	   background	   minimizes	   the	  
degree	  of	  variability	  in	  the	  cell	  phenotype.	  Moreover,	  THP-­‐1	  can	  be	  stored	  indefinitely	  
in	  liquid	  nitrogen.	  Following	  an	  appropriate	  procedure,	  this	  cell	   line	  can	  be	  recovered	  
without	   obvious	   detrimental	   effect	   on	   monocyte-­‐macrophage	   features	   and	   cell	  
viability	   (71).	   Once	   differentiated	   and	   activated,	   the	  macrophages	   produce	   ROS	   and	  






Figure	  3.3	  –	  Undifferentiated	  THP-­‐1	  cell	  line.	  	  
3.2.2 THP-1 differentiation and its activation   
THP-­‐1	   can	   be	   differentiated	   into	   macrophages	   by	   using	   PMA.	   Under	  
differentiation,	   the	   cells	   start	   to	   adhere	   to	   the	   cell	   culture	   flask	   and	   acquire	   a	  more	  
enlongated	  morphology	  that	  is	  maintained	  when	  macrophages	  are	  activated	  with	  LPS	  
(Figure	  3.4).	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PMA-­‐differentiated	  THP-­‐1	  cells	  enhance	  the	  phagocytic	  activity,	  release	  of	  O2
-­‐,	  
formation	   of	   tumour	   necrosis	   factor-­‐α	   (TNF-­‐α),	   and	   prostaglandin	   E2	   (PGE2)	   and	  
expression	  of	  the	  surface	  antigens	  CD11b	  and	  CD14.	  Lastly,	  phorbol	  esters	  are	  known	  
to	   activate	   protein	   kinase	   C	   	   (PKC).	   Indeed,	   after	   differentiation	  with	   phorbol	   esters	  
there	  is	  a	  translocation	  of	  PKC	  isoenzymes	  -­‐α	  and	  -­‐β	  to	  cellular	  membranes	  suggesting	  
that	  these	  isoenzymes	  might	  be	  involved	  in	  differentiation	  process	  (73).	  	  
LPS	   is	   a	   complex	   glycolipid	   composed	   of	   a	   hydrophilic	   polysaccharide	  moiety	  
and	   a	   hydrophobic	   domain	   known	   as	   lipid	   A.	   LPS	   induces	   the	   production	   of	  
proinflamatory	   cytokines	   in	   macrophages	   like	   TNF-­‐α	   and	   IL-­‐1,	   -­‐6,	   -­‐8,	   and	   -­‐12.	  
Moreover,	   when	   activated,	   macrophages	   also	   secrete	   other	   biological	   response	  
mediators	  including	  free	  radicals,	  such	  as	  nitric	  acid	  (74).	  	  
	  
Figure	  3.4	  –	  THP-­‐1	  derived	  macrophages	  (differentiated	  with	  PMA	  (48	  hrs)	  and	  subsequently	  activated	  with	  LPS	  (48	  
hrs))	  	  
As	   mentioned	   before,	   when	   macrophages	   are	   activated	   and	   exhibit	   an	  
inflammatory	   profile,	   they	   produce	   higher	   levels	   of	   ROS.	   To	   confirm	   this,	   levels	   of	  
intracellular	   ROS	   before	   and	   after	   macrophage	   activation	   were	   analysed	   by	   flow	  






	   	  
Non-­‐activated	  Macrophages	   Activated	  Macrophages	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Figure	  3.5	  –	  DCF	   fluorescence,	   (quantified	  by	   flow	  cytometry	  after	   the	  macrophages	  were	  1,5	  hrs	   in	  contact	  with	  
DCFDAH2)	   proportional	   to	   the	   intracellular	   ROS.	   Data	   represents	   the	   mean	   ±	   S.D,	   (n=2),	   **	   p	   <0,01	   within	   the	  
activated	  macrophages	  compared	  to	  the	  non-­‐activated	  macrophages	  as	  determine	  by	  t	  test.	  	  
	   	   The	   results	   show	   that	   when	   activated,	   macrophages	   present	   higher	  
fluorescence,	  which	   is	  proportional	  to	  the	  amount	  of	  ROS,	  comparatively	  to	  the	  non-­‐
activated	  macrophages.	  	  
3.2.3 Culture of Macrophages in a transwell system in the presence of TiO2 
powders 
	   In	  previous	  assays,	  it	  was	  established	  a	  model	  where	  the	  macrophages	  were	  in	  
direct	   contact	  with	   the	   powders.	   In	   this	  work,	   in	   order	   to	   resemble	   the	   BRB,	   it	  was	  
establish	   a	   transwel	   system	  where	  macrophages	  were	   placed	   in	   the	   apical	   side	   and	  
different	  powders	  at	  different	  concentrations	  in	  the	  basal	  side.	  	  
	  3.2.4	  Evaluation of the metabolic activity of macrophages  
The	  non-­‐activated	  or	  activated	  macrophages	  are	  placed	  into	  the	  apical	  side	  of	  
the	  transwell	  system	  and	  the	  TiO2	  powders	  on	  the	  basal	  side.	  	  
In	  order	  to	  investigate	  whether	  TiO2	  powders,	  even	  not	  being	  in	  direct	  contact,	  
presented	   a	   cytotoxic	   effect	   on	   non-­‐activated	   or	   activated	  macrophages,	   they	   were	  
incubated	  with	  distinguish	  types	  of	  TiO2	  powders	  at	  two	  different	  concentration.	  	  After	  
24h	   or	   48h	   of	   culture	   the	  metabolic	   activity	  were	   assessed	   by	   adding	   resazurin	   and	  
afterwards	  the	  fluorescence	  was	  measured	  (Figure	  3.6).	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Figure	   3.6	   –	   Cell	   metabolic	   activity	   after	   24h	   and	   48h	   of	   culture.	   A	   –	   Viability	   after	   24h	   of	   the	   non-­‐activated	  
macrophages.	   A	   –	   Viability	   after	   24h	   of	   the	   activated	  macrophages.	   C	   –	   Viability	   after	   48h	   of	   the	   non-­‐activated	  
macrophages.	  D	  –	  Viability	  after	  48h	  of	  the	  activated	  macrophages.	  Data	  represents	  the	  mean	  ±	  S.D,	  (n=2-­‐3),	  	  
The	   metabolic	   activity	   of	   macrophages	   was	   not	   significantly	   affected	   either	  
after	  24h	  or	  48h	  in	  the	  presence	  of	  the	  different	  TiO2	  calcined	  powders.	  	  
Our	  findings	  showed	  that	  macrophages	  maintained	  their	  metabolic	  activity	  and	  
are	  not	  suffering	  a	  direct	  toxic	  effect	  by	  these	  TiO2	  powders.	  Moreover,	  the	  increase	  of	  
TiO2	  concentration	  did	  not	  reduce	  nor	  increased	  the	  metabolic	  activity.	  	  
	  
3.2.5 Evaluation of the presence of ROS in the supernatant 
	  	   Since	  the	  TiO2	  powders	  do	  not	  affect	  cell	  metabolic	  activity,	  we	  proceed	  to	  the	  
analysis	  of	  the	  ROS	  scavenging	  capacity	  of	  the	  powders.	  We	  analysed	  the	  ROS	  released	  
by	  the	  cells	  to	  the	  medium,	  here	  after	  referred	  as	  extracellular	  ROS	  and	  the	  ROS	  the	  is	  
retained	  inside	  the	  cells,	  here	  after	  referred	  as	  intracellular	  ROS.	  	  	  
Once	  it	  was	  shown	  that	  the	  metabolic	  activity	  is	  not	  affected	  in	  the	  presence	  of	  
the	  TiO2	  powders	  at	  different	  concentrations	  and	  taking	  into	  account	  previous	  results	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where	   the	  macrophages	  were	   in	   direct	   contact	  with	   the	  powders,	   it	  was	   decided	   to	  
pursue	  the	  analysis	  after	  48h	  under	  the	  presence	  of	  powders.	  	  In	  this	  regard,	  Figure	  3.7	  

























Figure	  3.7	  –	  DCF	  fluorescence,	  proportional	  to	  the	  extracellular	  ROS	  after	  48h	  of	  culture	  in	  the	  presence	  of	  powders.	  
A	  –	  Extracellular	  ROS	  of	  the	  non-­‐activated	  macrophages.	  B	  –	  Extracellular	  ROS	  of	  the	  activated	  macrophages.	  Data	  
represents	  the	  mean	  ±	  S.D,	  (n=2),	  ***	  p	  <0,001,	  ****	  p	  <0,0001	  within	  supernatant	  from	  the	  basal	  side	  compared	  
with	  the	  supernatant	  from	  the	  apical	  side	  in	  the	  absence	  of	  powders	  and	  within	  supernatant	  from	  the	  basal	  side	  in	  
the	  presence	  of	  1	  mg/ml	  of	  the	  TiO2	  powders	  compared	  to	  the	  supernatant	  from	  the	  basal	  side	  in	  the	  absence	  of	  
powders.	  These	  statistic	  differences	  were	  determined	  by	  2way	  ANOVA,	  using	  Tukey’s	  multiple	  comparison	  test.	  	  	  
First	  of	  all,	   it	   is	   important	  to	  mention	  that	   in	  both,	  non-­‐activated	  or	  activated	  
macrophages,	   the	   ROS	   levels	   normally	   follow	   the	   same	   tendency	   but	   yet	   the	   initial	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levels	  of	  supernatant	  ROS	  in	  the	  activated	  macrophages	  were	  higher	  than	  in	  the	  non-­‐
activated	  macrophages.	  	  
After	  48h	  of	  culture,	  when	  there	  are	  no	  TiO2	  powders	  in	  the	  system,	  there	  is	  a	  
residual	   ROS	   level	   on	   the	   apical	   side	   that	   is	   significantly	   lower	   comparatively	   to	   the	  
ROS	   levels	   on	   basal	   side.	   This	   result	   suggests	   that	   upon	   ROS	   production	   by	  
macrophages	  in	  the	  apical	  side	  they	  move	  into	  the	  basal	  side.	  	  
Furthermore,	  when	  1	  mg/ml	  of	  TiO2	  powder	  is	  introduced	  into	  the	  system	  the	  
ROS	  levels	  are	  significantly	  reduced,	  with	  the	  exception	  of	  200°C	  powder,	  where	  it	  was	  
not	   observed	   any	  differences	   relatively	   to	   the	  ROS	   levels	   in	   the	   absence	  of	   the	   TiO2	  
powder.	  The	  same	  profile	  is	  observed	  when	  the	  concentration	  of	  the	  different	  types	  of	  
TiO2	  powders	   is	   increased.	   Therefore,	   these	   results	   suggest	   that	   the	   increase	   in	   TiO2	  
concentration	  do	  not	   improve	   the	  ROS	   scavenging	   capacity.	  Moreover,	   these	   results	  
show	  that	  the	  200°C	  powder	  does	  not	  play	  a	  key	  role	  in	  the	  scavenging	  capacity	  of	  ROS	  
species,	  even	  at	  higher	  concentrations.	  	  
 
3.2.6 Evaluation of the presence of ROS inside the cells  
Similar	  to	  the	  previous	  result,	  the	  intracellular	  ROS	  were	  analysed	  after	  48h	  of	  
culture	  with	  TiO2	  powders	  (Figure	  3.8).	  
	  
	  
Figure	  3.8	  –	  DCF	  fluorescence	  after	  48h	  of	  culture	  in	  the	  presence	  of	  powders,	  (quantified	  by	  flow	  cytometry	  after	  
the	  macrophages	  were	  1,5	  hrs	  in	  contact	  with	  DCFDAH2)	  proportional	  to	  the	  intracellular	  ROS.	  A	  –	  Extracellular	  ROS	  
of	  the	  non-­‐activated	  macrophages.	  B	  –	  Extracellular	  ROS	  of	  the	  activated	  macrophages.	  Data	  represents	  the	  mean	  ±	  
S.D,	  (n=3-­‐4),	  ****	  p	  <0,0001	  within	  the	  non-­‐activated	  or	  activated	  macrophages	  in	  the	  presence	  of	  1	  mg/ml	  and	  5	  
mg/ml	  of	  the	  TiO2	  powders	  compared	  to	  the	  cells	  without	  powders.	  These	  statistic	  differences	  are	  determined	  by	  
2way	  ANOVA	  test.	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When	   non-­‐activated	   macrophages	   were	   in	   the	   presence	   of	   different	   TiO2	  
powders	   at	   different	   concentrations	   (Figure	   3.8A),	   it	   was	   possible	   to	   observe	  
fluorescence,	  proportional	  to	  the	  ROS	  levels,	  which	  increases	  with	  more	  significance	  in	  
the	  presence	  of	  5	  mg/ml	  of	  TiO2	  powders	  comparatively	  to	  the	  transwell	  system	  in	  the	  
absence	  of	  TiO2	  powders.	  Under	   illumination	  with	   light,	  TiO2	  causes	   severe	  oxidative	  
damage	  to	  cells	  (75),	  which	  leads	  to	  the	  generation	  of	  ROS.	  Nevertheless,	  this	  increase	  
is	  not	  comparable	  to	  the	  observed	  upon	  macrophage	  activation	  with	  LPS.	  	  
Under	   an	   inflammatory	   profile	   and	   in	   the	   absence	   of	   powders,	   the	  
macrophages	   produce	   higher	   levels	   of	   ROS	   as	   showed	   by	   the	   higher	   values	   of	  
fluorescence	   in	   Figure	   3.8B.	   Importantly,	   the	   fluorescence	  when	   these	  macrophages	  
are	  in	  the	  presence	  of	  the	  powders	  is	  significantly	  reduced,	  which	  reflects	  a	  reduction	  
of	   the	   ROS	   levels.	   Within	   the	   same	   concentration	   of	   TiO2	   powder	   and	   comparing	  
different	   types	  of	  TiO2	  powders	   there	   is	  no	   significant	  difference	   in	   the	   fluorescence	  
values.	   Additionally,	   a	   similar	   result	   is	   obtained	   when	   compared	   the	   two	   different	  
concentrations	  of	  TiO2	  powders.	  	  
The	   ROS	   released	   by	   macrophages	   are	   scavenged	   for	   the	   TiO2	   powders,	  
therefore	   it	   is	   hypothesized	   that	   they	   lead	   to	   the	   reduction	   of	   the	   oxidant	   stress	   in	  
macrophages	   and	   consequently	   TiO2	   powders	   could	   halt	   the	   ROS	   overproduction	   by	  
the	  cells.	  	  	  	  	  
	  
3.3 Bioreactor 
3.3.1 Evaluation of the permeability of the system with methylene blue   
The	  permeability	  is	  an	  important	  and	  essential	  characteristic	  of	  the	  bioreactor	  
system.	   This	   feature	  was	   the	   first	   one	   to	   be	   assessed	   (Figure	   3.9),	   using	  methylene	  
blue.	  Since	  it	  is	  a	  blue	  dye	  and	  the	  diffusion	  profile	  is	  easily	  observed	  due	  to	  the	  colour	  
change	   in	   the	   bottom	   chamber.	   The	   methylene	   blue	   solution	   was	   in	   the	   upper	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Figure	  3.9	  –	  Methylene	  blue	  diffusion	  from	  the	  upper	  to	  the	  bottom	  chamber	  through	  the	  polycarbonate	  membrne	  	  
This	   characteristic	  was	   tested	  under	   static	   conditions	  and	  dynamic	   conditions	  
(Figure	  3.10).	  	  
Figure	  3.10	  –	  Graphic	  representation	  of	  the	  methylene	  blue	  diffusion	  from	  the	  upper	  to	  the	  bottom	  chamber.	  A	  –	  
Methylene	  blue	  diffusion	  under	   static	   conditions.	   B	   –	  Methylene	  blue	  diffusion	  under	  dynamic	   conditions	  with	   a	  
flow	  rate	  of	  150	  µl/min	  and	  300	  µl/min	  for	  the	  bottom	  and	  upper	  chamber,	  respectively.	  Data	  represents	  the	  mean	  
±	  S.D,	  (n=3).	  	  	  	  	  
	  
The	  diffusion	  of	  methylene	  blue,	  under	  static	  conditions,	   is	  gradual	  during	  the	  
first	  hour	  and	  afterwards	  it	  is	  achieved	  a	  plateau	  region,	  when	  approximately	  20	  %	  of	  
the	  methylene	   blue	   solution	   riches	   the	   bottom	   chamber.	   Under	   dynamic	   conditions	  
the	  stabilization	  of	   the	  diffusion	   is	  achieved	  earlier,	  after	  30	  min.	  This	   stabilization	   is	  
achieved	  after	  10%	  of	  methylene	  blue	  passes	  through	  the	  membrane.	  It	  was	  expected	  
that	  the	  decrease	  of	  methylene	  blue	  in	  the	  upper	  chamber	  was	  similar	  to	  the	  increase	  
in	   the	   bottom	   chamber.	   However,	   according	   to	   the	   results	   obtained	   that	   is	   not	   the	  
case,	  because	  we	  observe	   that	  a	  50%	  equilibrium	   in	  not	   reached	   in	  both	   conditions.	  
Therefore,	  the	  polycarbonate	  membrane	  acts	  as	  a	  barrier	  system	  where	  the	  methylene	  
blue	  tends	  to	  deposit	  on	  the	  apical	  side	  of	  the	  membrane	  without	  translocation	  to	  the	  
basal	  side.	  This	  effect,	  what	  was	  already	  observed	  in	  (76)	  is	  more	  representative	  under	  
static	  conditions.	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3.3.2 Evaluation of the ROS passage through the polycarbonate membrane 
– DPPH and SIN-1     
	  
The	   next	   step	   was	   to	   evaluate	   the	   passage	   of	   ROS	   molecules	   through	   the	  
membrane	  from	  the	  upper	  to	  the	  bottom	  chamber.	  Firstly,	   the	  assay	  was	  performed	  








Figure	   3.11	   –	  Graphic	   representation	  of	   the	  DPPH	  diffusion	   from	   the	  upper	   to	   the	  bottom	   chamber	  under	   static	  
conditions.	  	  
The	  diffusion	  of	  DPPH	  through	  the	  membrane	  under	  static	  conditions	  is	   linear	  
during	  the	  4h	  of	  the	  assay.	  It	  was	  not	  observed	  a	  stabilization	  of	  the	  diffusion	  similar	  to	  
what	  occurs	  in	  the	  methylene	  blue	  assay.	  It	  was	  observed	  a	  diffusion	  approximately	  of	  
35	  %	  of	  DPPH	  from	  the	  upper	  to	  the	  bottom	  chamber.	  The	  decay	  of	  the	  percentage	  in	  
DPPH	  recorded	  in	  the	  upper	  chamber	  is	  similar	  to	  the	  increase	  in	  the	  bottom	  chamber.	  
Nevertheless	  at	  the	  time	  point	  of	  4h	  the	  solution	  from	  the	  upper	  chamber	  evaporates	  
creating	  bubbles.	  Consequently	  the	  concentration	  of	  the	  solutions	  was	  altered	  and	  also	  
the	  pressure	  system	  was	  not	  maintained.	  In	  this	  regard	  this	  assay	  was	  not	  performed	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Figure	  12	  –	  Graphic	  represents	  the	  SIN-­‐1	  diffusion	  from	  the	  upper	  to	  the	  bottom	  chamber.	  A	  –	  SIN-­‐1	  diffusion	  under	  
static	  conditions.	  B	  –	  SIN-­‐1	  diffusion	  under	  dynamic	  conditions	  with	  a	  flow	  rate	  of	  150	  µl/min	  and	  300	  µl/min	  for	  the	  
bottom	   and	   upper	   chamber,	   respectively.	   C	   –	   SIN-­‐1	   diffusion	   under	   dynamic	   conditions	  with	   a	   flow	   rate	   of	   200	  
µl/min	  and	  400	  µl/min	  for	  the	  bottom	  and	  upper	  chamber,	  respectively.	  Data	  represents	  the	  mean	  ±	  S.D,	  (n=2-­‐4).	  	  	  	  	  
	  
Identically	  to	  the	  methylene	  blue	  results,	  the	  diffusion	  of	  SIN-­‐1	  through	  the	  
membrane	  occurs	  gradually	  and	  a	  steady	  state	  is	  finally	  achieved.	  The	  gradual	  diffusion	  
of	  SIN-­‐1	  under	  static	  condition	  (Figure	  12A)	  occurs	  for	  a	  period	  of	  2h,	  while	  in	  dynamic	  
conditions	  there	  is	  stabilization	  after	  30	  min.	  We	  can	  observe	  a	  decrease	  of	  about	  40%	  
of	   SIN-­‐1	   in	   the	  upper	   chamber.	  However,	   in	   the	  bottom	  chamber	  only	   20%	  of	   SIN-­‐1	  
was	  detected,	  which	  may	  indicate	  that	  some	  SIN-­‐1	  is	  being	  retained	  in	  the	  membrane,	  
nonetheless	   contrasting	   to	   the	  methelyne	   blue	   results	   this	   effect	   is	  more	   significant	  
under	  dynamic	  conditions.	  	  Moreover,	  it	  was	  tested	  if	  by	  increasing	  the	  flow	  rate	  was	  
possible	  to	  modify	  the	  diffusion	  profile	  of	  SIN-­‐1.	  As	  it	  is	  possible	  to	  observe	  on	  Figure	  
12B	  and	  C	  this	  increase	  did	  not	  change	  the	  diffusion	  profile	  through	  the	  membrane.	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3.3.4 Culture of Macrophages in the bioreactor system 	  
Once	   established	   the	   transwell	   model,	   we	   aiming	   to	   implement	   dynamic	  
conditions	   and	   conduct	   similar	   assays	   with	   the	   previous	   ones.	   In	   this	   regard	   it	   was	  
established	  at	  the	  same	  time	  a	  static	  system	  as	  control	  and	  a	  dynamic	  system	  with	  a	  
flow	  rate	  of	  150	  µl/min	  for	  the	  bottom	  chamber	  and	  300	  µl/min	  upper	  chamber	  either	  
with	  non-­‐activated	  activated	  macrophages.	  The	  previous	  assays	  were	  performed	  after	  
48	  hrs	  of	  incubation,	  therefore,	  in	  this	  assay	  was	  used	  the	  same	  time	  point.	  	  
 
Cell metabolic activity and evaluation the presence of ROS in the 
supernatant  
	  
Firstly,	   it	   was	   evaluated	   whether	   to	   implement	   dynamic	   conditions,	   the	   cell	  
metabolic	  activity	  decreased	  (figure	  3.13)	   
Figure	  3.13	  –	  Cell	  metabolic	  activity	  under	  static	  and	  dynamic	  conditions.	  A	  –	  Cell	  metabolic	  activity	  of	  non-­‐activated	  
macrophages.	  B	  –	  Cell	  metabolic	  activity	  of	  activated	  macrophages.	  Data	  represents	  the	  mean	  ±	  S.D,	  (n=1-­‐2).	  	  	  	   
 
The	  cell	  metabolic	  activity	  from	  both	  non-­‐activated	  and	  activated	  macrophages	  
is	   significantly	   reduced	  when	   dynamic	   conditions	  were	   implemented.	   This	   reduction	  
may	  have	  occurred	  due	   to	   the	   established	   flow	   rate.	   Firstly,	   in	   order	   to	   confirm	   the	  
observed	   results	   we	   should	   make	   further	   replicas.	   Furthermore,	   other	   flow	   rates	  
should	  be	  tested	  in	  order	  to	  find	  out	  if	  reducing	  the	  flow	  rate	  it	  is	  possible	  to	  increase	  
the	  cell	  metabolic	  activity.	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Despite	   the	   reduction	   in	   cell	   metabolic	   activity	   under	   dynamic	   conditions,	   it	  
was,	  subsequently,	  analyzed	  the	  presence	  of	  ROS	  on	  both	  chambers	  (figure	  3.14).	  	  	  
Figure	   3.14	   –	   DCF	   fluorescence,	   proportional	   to	   the	   extracellular	   ROS	   on	   the	   upper	   and	   bottom	   chamber	   under	  
static	   and	   dynamic	   conditions.	   A	   –	   ROS	   of	   non-­‐activated	  macrophages.	   B	   –	   ROS	   of	   activated	  macrophages.	   Data	  
represents	  the	  mean	  ±	  S.D,	  (n=1-­‐2).	  	  	  	   
	  
In	  both	  non-­‐activated	  and	  activated	  macrophages	  and	  also	  either	  under	  static	  
or	  dynamic	  conditions	  the	  ROS	  levels	  in	  the	  bioreactor	  chambers	  is	  identically.	  	  
Whilst	   there	   is	   no	   significant	   difference	   between	   of	   static	   and	   dynamic	  
conditions	  from	  the	  non-­‐activated	  macrophages,	  there	  is	  an	  increment	  of	  fluorescence	  
when	  non-­‐activated	  macrophages	  were	   subjected	   to	  dynamic	   conditions,	  which	  may	  
indicate	  that	  the	  flow	  rate	  applied	  could	  induce	  the	  cell	  activation.	  Nevertheless,	  due	  
to	   the	   low	   cell	   viability	  under	  dynamic	   conditions,	   the	   respective	  ROS	   results	   should	  
not	   be	   taking	   into	   account.	   To	   be	   certain	   of	   this	   result,	   more	   replicas	   should	   be	  
performed.	  Moreover,	  other	  flow	  rates	  should	  be	  tested	  in	  order	  to	  evaluate	  in	  which	  
one	  we	  can	  maintain	  the	  non-­‐activated	  state.	   
	  
Finally	   on	   this	   point,	   it	   was	   also	   addressed	   the	   incorporation	   of	   the	   TiO2	  
powders	   on	   the	   system.	   Nevertheless,	   and	   knowing	   that	   the	   TiO2	   powder	   in	   the	  
medium	  forms	  a	  suspension	  instead	  of	  a	  solution,	  the	  presence	  of	  loose	  TiO2	  powders	  
in	   the	   system	   clogs	   the	   system	   and	   thereby	   preventing	   the	   normal	   flow	   rate	   and	  
consequently	  the	  presence	  of	  a	  laminar	  flow.	  To	  circumvent	  this	  problem,	  we	  tried	  to	  
incorporated	  the	  TiO2	  powder	  into	  a	  hydrogel,	  but	  without	  success	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Conclusions and future perspectives 
	   As	  more	   relevant	   conclusion	   remark,	   this	   work	   allows	   to	   conclude,	   either	   by	  
chemical	   or	   biological	   tests,	   that	   TiO2	   powders	   presented	   a	   high	   ROS	   scavenging	  
capacity,	  especially	  the	  200°C	  and	  600°C	  calcined	  powders.	  	  
Regarding	  the	  chemical	  assays,	  where	  the	  ROS	  scavenging	  capacity	  of	  different	  
calcined	   TiO2	   powders	   (204757	   commercial,	   200°C,	   600°C	   and	   700°C)	   along	   with	  
mixtures	  of	  different	  ratios	  of	  200°C	  and	  700°C	  TiO2	  powders	  were	  tested.	  Our	  findings	  
indicated	   that	   the	   200°C	   and	   600°C	   presented	   the	   best	   ROS	   scavenging	   capacity.	  
Moreover,	  the	  mixtures	  of	  the	  different	  powders	  did	  not	  improve	  the	  ROS	  scavenging	  
capacity.	  	  
Once	   completed	   the	   chemical	   assays,	   it	   was	   used	   ROS	   produced	   by	  
macrophages	   in	   order	   to	   understand	   if	   the	   ROS	   scavenging	   capacity	   of	   the	   most	  
promising	   powders	   was	   maintained.	   In	   order	   to	   obtain	   a	   close-­‐up	   view	   of	   what	  
happens	   in	   vivo	   where	   the	   macrophages	   are	   not	   in	   direct	   contact	   with	   the	   TiO2	  
particles,	   it	   was	   used	   a	   trans-­‐well	   system	   (macrophages	   in	   the	   apical	   side	   and	   TiO2	  
powders	   in	   the	   basal	   side).	   	   Two	   different	   concentrations	   of	   the	   200°C	   and	   600°C	  
calcined	  TiO2	  powders	  were	   tested,	  1	  mg/ml	  and	  5	  mg/ml,	  and	  our	   findings	   indicted	  
that,	  with	  both	   concentrations,	   the	  macrophages	  metabolic	   activity	  was	  maintained,	  
and	   therefore,	   the	   powder	   had	   non-­‐toxic	   properties	   at	   these	   concentrations.	  
Regarding	  the	  ROS	  scavenging	  capacity,	  both	  powders	  as	  well	  as	  both	  concentrations	  
revealed	  a	  similar	  profile.	  There	  was	  a	  significantly	  reduction	  of	  the	  ROS	  levels	  -­‐	  both	  
extracellular	  ROS	  and	  intracellular	  ROS	  -­‐	  in	  the	  presence	  of	  the	  TiO2	  powders.	  	  	  	  	  	  	  	  
	   Finally,	   regarding	   the	  bioreactor	   system,	   it	  was	   evaluated	   the	  permeability	   of	  
the	   used	  membrane	  by	   placing	   on	   the	  upper	   chamber	   a	   solution	  of	  methylene	  blue	  
and,	  thereafter,	  artificial	  ROS.	  It	  was	  possible	  to	  observe	  a	  gradient	  of	  diffusion	  either	  
of	  methylene	  blue	  or	  artificial	  ROS	  through	  the	  bioreactor	  membrane.	  Additionally,	   it	  
was	   seen	   interactions	   between	   the	   analysed	   compounds	   and	   the	   polycarbonate	  
membrane.	  Once	  this	  assay	  was	  concluded,	  some	  preliminary	  assays	  were	  performed	  
with	  macrophages.	   The	   cells	  were	   seeded	   in	   	   the	  membrane	   and	   a	   flow	   rate	   –	   300	  
µl/min	   for	   the	   upper	   chamber	   and	   150	   µl/min	   for	   the	   bottom	   chamber	   –	   was	  
established.	   The	   results	   reveal	   a	   marked	   decrease	   in	   the	   cell	   viability	   when	   the	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dynamic	  conditions	  were	   implemented.	  Concerning	  the	  ROS	   levels,	   they	  were	  similar	  
for	   both	   conditions	   and	   also	   for	   the	   non-­‐activated	   and	   activated	   macrophages.	  
Nevertheless,	  a	  slightly	  increase	  in	  the	  ROS	  levels	  from	  the	  non-­‐activated	  macrophages	  
when	  established	   the	  dynamic	   conditions	   indicate	   a	  possible	  macrophage	  activation.	  
However,	   as	   preliminary	   assays,	   it	   should	   be	   performed	   more	   replicas	   and	   tested	  
different	  flow	  rates.	  	  	  	  	  
In	  conclusion,	  our	  results	  allow	  to	  consider	  that	  TiO2	  is	  a	  promising	  biomaterial	  
regarding	  its	  ROS	  scavenging	  capacity,	  with	  a	  particular	  focus	  on	  the	  200°C	  and	  600°C	  
calcined	  powders.	  Regarding	   the	  bioreactor	   system,	   the	   results	   allow	  us	   to	   conclude	  
that	  this	  is	  a	  useful	  tool	  enabling	  the	  study	  of	  applied	  flow	  through	  a	  cell	  culture	  and	  
further	  simulate	  the	  eye	  environment.	  	  
Future	  work	  concerning	  the	  transwell	  system	  with	  macrophages	  should	  include	  
the	   analysis	   of	   anti-­‐	   and	   pro-­‐inflammatory	   cytokines	   such	   as	   IL-­‐10	   and	   TNF-­‐α.	  
Regarding	   the	   bioreactor	   system	   with	   the	   macrophages	   other	   flow	   rates	   should	   be	  
tested	   and	   also	   the	   TiO2	   powders,	   which	   in	   this	   case	   should	   be	   incorporated	   in	   the	  
PMMA	   substrate.	   Furthermore	   as	   future	   work	   to	   this	   project	   should	   include	   the	  
introduction	  of	  more	  complexity	  to	  the	  model.	  Namely,	  by	  the	  use	  of	  endothelial	  and	  
RPE	  cells	  both	  constituents	  of	   the	  oBRB.	   In	   this	   context,	  we	  could	  simulate	  oxidative	  
stress	  into	  the	  cells	  that,	  consequently,	  leads	  to	  ROS	  production.	  In	  this	  way	  we	  could	  
evaluate	  the	  effect	  of	  different	  TiO2	  powders	  at	  the	  BRB	  level.	  This	  model	  should	  firstly	  
be	   implemented	   under	   static	   conditions	   and	   then,	   in	   order	   to	   mimic	   the	   in	   vivo	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Appendices  
Appendix A 	  
The	   following	   tables	   describe	   the	   supplier	   and	   the	   associated	   reference,	   for	  
each	  material.	  	  
Chemical Assays  
1. 2,2-­‐diphenyl-­‐1-­‐picrylhydrazyl	  (DPPH)	  in	  the	  presence	  of	  titanium	  dioxide	  	  (TiO2)	  	  	  	  
Material	   Supplier	  /	  Reference	  	  
2,2-­‐diphenyl-­‐1-­‐picrylhydrazyl	  (DPPH)	  	   Sigma	  Aldrich®	  /	  D9132	  
Isopropanol	   JMGS	  /	  20904,362	  
Titanium	  dioxide	  (TiO2)	  	   Sigma	  Aldrich
®	  /	  204757	  	  
TiO2	  200°C	  	   -­‐-­‐	  
TiO2	  700°C	   -­‐-­‐	  
	  
2. 3-­‐Morpholinosyndnomine	  (SIN-­‐1)	  in	  the	  presence	  of	  titanium	  dioxide	  	  (TiO2)	  	  	  	  
Material	   Supplier	  /	  Reference	  	  
3-­‐Morpholinosyndnomine	  	  (SIN-­‐1)	  	   Sigma	  Aldrich®	  /	  M5793	  
2'-­‐7'-­‐dichlorodihydrofluorescein	  diacetate	  
(DCFDAH2)	  
Molecular	  Probes®	  (Invitrogen)	  /	  C-­‐400	  
KOH	   EMSURE®	  (Merck	  milipore)	  /	  105033	  
Phosphate	  buffered	  saline	  (PBS)	  	  
	  	  	  Sodium	  Chloride	  (NaCl)	  
	  	  	  Potassium	  Chloride	  (KCl)	  
	  	  	  Sodium	  phosphate	  dibasic	  (Na2HPO4)	  
	  	  	  Monopotassium	  phosphate	  (KH2PO4)	  
	  
EMSURE®	  (Merck	  milipore)	  /	  106404	  
Sigma	  Aldrich®	  /	  P8041	  
EMSURE®	  (Merck	  milipore)	  /	  S106586	  
Sigma	  Aldrich®	  /	  P5655	  
Artificial	  cerebrospinal	  fluid	  (aCSF)	  
	  	  	  Sodium	  Chloride	  (NaCl)	  
	  	  	  Calcium	  Chloride	  (CaCl2)	  
	  	  	  Potassium	  Chloride	  (KCl)	  	  
	  	  	  D-­‐Glucose	  	  
	  	  	  Magnesium	  chloride	  (MgCl2)	  
	  	  	  Phosphate	  buffered	  saline	  (PBS)	  	  
	  
EMSURE®	  (Merck	  milipore)	  /	  106404	  
EMSURE®	  (Merck	  milipore)	  	  /	  102378	  
	  Sigma	  Aldrich®	  /	  60133	  
Fisher	  Chemical	  /	  G/0500/60	  	  
EMSURE®	  (Merck	  milipore)	  /	  105833	  
Titanium	  dioxide	  (TiO2)	  	   Sigma	  Aldrich
®	  	  /	  204757	  	  
TiO2	  200°C	  	   -­‐-­‐	  
TiO2	  700°C	  	   -­‐-­‐	  
 
Cell Culture  
1. Human	   monocytic	   leukemia	   cell	   line	   (THP-­‐1)	   propagation,	   cell	   differentiation	   into	  
macrophages	  and	  activation	  	   
Material	   Supplier	  /	  Reference	  
RPMI	  1640	  GlutaMax	   Gibco®	  (Life	  Technologies)	  /	  61870-­‐010	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2. Transwell	  Assays:	  evaluate	  the	  viability,	  presence	  of	  ROS	  in	  the	  supernatant	  and	  inside	  
the	  cell	  	  
Material	   Supplier	  /	  Reference	  
Transwell	  inserts	   VWR	  (Corning®)	  /	  29442-­‐086	  
RPMI	  1640	  GlutaMax	  	   Gibco®	  (Life	  Technologies)	  /	  61870-­‐010	  
Fetal	  Bovine	  Serum	  (FBS)	   Sigma	  Aldrich®	  /	  F7524	  
Penicillin	  /	  Streptomycin	  	   Gibco®	  (Invitrogen)/	  15140-­‐122	  	  
Phosphate	  buffered	  saline	  (PBS)	  	  
	  	  	  Sodium	  Chloride	  (NaCl)	  
	  	  	  Potassium	  Chloride	  (KCl)	  
	  	  	  Sodium	  phosphate	  dibasic	  (Na2HPO4)	  
	  	  	  Monopotassium	  phosphate	  (KH2PO4)	  
	  
EMSURE®	  (Merck	  milipore)	  /	  106404	  
Sigma	  Aldrich®	  /	  P8041	  
EMSURE®	  (Merck	  milipore)	  /	  S106586	  
Sigma	  Aldrich®	  /	  P5655	  
Titanium	  dioxide	  (TiO2)	  	   Sigma	  Aldrich
®	  	  /	  204757	  	  
2'-­‐7'-­‐dichlorodihydrofluorescein	  diacetate	  
(DCFDAH2)	  
Molecular	  Probes®	  (Invitrogen)	  /	  C-­‐400	  
Resazurin	  	   Sigma	  Aldrich®	  	  /	  R7017	  
TiO2	  200°C	  	   -­‐-­‐	  






Fetal	  Bovine	  Serum	  (FBS)	   Sigma	  Aldrich®	  /	  F7524	  
Penicillin	  /	  Streptomycin	  	   Gibco®	  (Invitrogen)/	  15140-­‐122	  	  
Trypsin	  	   Sigma	  Aldrich®	  /	  T0646	  
Phorbol	  12-­‐myristate	  13-­‐acetate	  (PMA)	  	   Sigma	  Aldrich®	  /	  P8139	  
Bacterial	  lipopolysaccharide	  (LPS)	   Sigma	  Aldrich®	  /	  L6529	  
Material	   Supplier	  /	  Reference	  
Polycarbonate	  Membrane	  	   Sigma	  Aldrich®	  /	  P9449-­‐100EA	  
3-­‐Morpholinosyndnomine	  	  (SIN-­‐1)	  	   Sigma	  /	  M5793	  
Artificial	  cerebrospinal	  fluid	  (aCSF)	  
	  	  	  Sodium	  Chloride	  (NaCl)	  
	  	  	  Calcium	  Chloride	  (CaCl2)	  
	  	  	  Potassium	  Chloride	  (KCl)	  	  
	  	  	  D-­‐Glucose	  	  
	  	  	  Magnesium	  chloride	  (MgCl2)	  
	  	  	  Phosphate	  buffered	  saline	  (PBS)	  
	  	  	  	  	  	  	  Sodium	  Chloride	  (NaCl)	  
	  	  	  	  	  	  	  Potassium	  Chloride	  (KCl)	  
	  	  	  	  	  	  	  Sodium	  phosphate	  dibasic	  (Na2HPO4)	  
	  	  	  	  	  	  	  Monopotassium	  phosphate	  (KH2PO4)	  
	  
EMSURE®	  (Merck	  milipore)	  /	  106404	  
EMSURE®	  (Merck	  milipore)	  	  /	  102378	  
	  Sigma	  Aldrich®	  /	  60133	  
Fisher	  Chemical	  /	  G/0500/60	  	  
EMSURE®	  (Merck	  milipore)	  /	  105833	  
	  
EMSURE®	  (Merck	  milipore)	  /	  106404	  
Sigma	  Aldrich®	  /	  P8041	  
EMSURE®	  (Merck	  milipore)	  /	  S106586	  
Sigma	  Aldrich®	  /	  P5655	  
2,2-­‐diphenyl-­‐1-­‐picrylhydrazyl	  (DPPH)	  	   Sigma	  Aldrich®	  	  /	  D9132	  
Isopropanol	   JMGS	  /	  20904,362	  
